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Abstract 
 
Carbohydrates are implicated in a large number of biological processes ranging from cell-cell 
interactions to bacterial and viral infection. Lectins are carbohydrate-binding proteins that are 
generally specific for certain sugars. However, typical carbohydrate–lectin interactions tend to 
have very low monomeric binding affinities. In many cases, the binding of saccharide ligands by 
protein receptors can be improved significantly through the attachment of multiple saccharide 
residues to a common support. Dendronized polymers constitute a class of macromolecules 
whose nanoscale size, rigidity, and functionality can be controlled with precision by tuning their 
molecular architecture. It is hypothesized that due to their large size and tunable properties, 
carbohydrate-functionalized dendronized polymers can be designed to be highly efficient ligands 
for lectins. In the current work, we generated a library of dendronized polymers, with different 
generations of mannose-terminated dendrons conjugated to a polycaprolactone backbone to 
study their lectin binding abilities. This work also describes the self-assembly of amphiphilic 
linear-dendron hybrids synthesized from galactose-functionalized dendrons coupled with a linear 
polypeptide poly-γ-benzyl-L-glutamate (PBLG). Collectively, this work provides the synthesis 
and applications of mannose and galactose based glycodendrons and their applications in ultra-
high multivalent scaffolds and self-assembled structures for carbohydrate-lectin binding studies. 
Keywords 
Dendron, Click chemistry, Dendronized polymers, Glycodendrons, Multivalent mannose, 
Multivalent galactose, Polycaprolactone 
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Chapter 1 
1 Introduction: 
1.1 Carbohydrates: Role in biology and medicine 
1.1.1 General role of carbohydrates in biology 
Polypeptides, polynucleotides and polysaccharides are the three main classes of biopolymers. 
Among these, polysaccharides or carbohydrates are a particularly diverse class that are made up 
of monosaccharide units as building blocks with a variety of stereochemical linkages, branching, 
as well as chain lengths among them. These carbohydrates exist in different forms in the body, 
for example as polysaccharides, glycopeptides, glycolipids, glycoaminoglycans, or other 
glycoconjugates. A vast amount of literature and experimental data exists for the study of 
proteins and nucleic acids and their interdependence and mutual interactions but because of the 
complexity, structural diversity and synthetic intricacies of higher polysaccharides, their direct 
applications in the field of medicine has not received as much attention as their two 
counterparts
1
. 
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Figure 1.1: Biopolymer interactions 
In recent years, studies have been done to learn about the role of carbohydrates in many of the 
biological processes in the body. A variety of natural products have been synthetically modified 
to their carbohydrate derivatives and have been proven to exhibit similar biological activity to 
their parent compounds while simultaneously having decreased toxicity and enhanced 
solubility
2
. For example, the aureolic acid group present on several compounds is considered to 
be an antimicrobial agent active against mycobacteria. One particular carbohydrate derivative of 
this group of compounds, chromomycin A3 (figure 1.2), is used clinically as an antitumor agent, 
specifically as an inhibitor of DNA-dependent RNA polymerase. Degradation experiments on 
3 
 
this molecule suggested that the activity and the binding of this molecule with DNA decreased 
with decreasing numbers of sugar groups
3
. 
 
Figure 1.2: Structure of chromomycin A 
Several proteins active in the body have acquired carbohydrate-binding active centres or 
‘modules’ that perform multiple biological functions. These modules, called the carbohydrate-
binding modules (CBMs) are highly carbohydrate selective and are capable of recognizing a 
variety of polysaccharides such as cellulose, chitin, β-glucans, starch, glycogen, inulin, pullulan, 
xylan, and many other different sugars such as arabinofuranose, mannan, fucose, lactose, 
galactose, polygalacturonic acid, β-D-galactosyl-1,4-β-D-N-acetylglucosamine, lipopolysac- 
charides etc
4
. 
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Carbohydrates also play a major role in cell-cell interaction processes. Cells have complex 
carbohydrates coating their surfaces and with the help of receptor-ligand interactions, a variety of 
cell-events can be triggered. In certain cases, the carbohydrates can be recognised by other, 
complementary carbohydrates in order to initiate these events. For example, corneal epithelial 
cells express a glycoprotein bearing the glycan determinant Le
x
. These kinds of cell-cell 
interactions mediated by Le
x 
are responsible for mechanisms mediating corneal epithelial cell 
differentiation
5
. 
Aside from cell-cell and cell-material interactions, carbohydrate literature contains many 
examples describing their role in reinforcing cell-microbe interactions. For example, Vibrio 
cholerae is a gram-negative, comma-shaped bacterium that releases the toxin that causes cholera. 
This toxin is a multisubunit, carbohydrate-binding protein that belongs to the family of AB5 
toxins. Its B subunits are capable of binding to the carbohydrate part of the GM1 ganglioside on 
the intestinal cell surface and the A subunit internalizes the toxin, thus initiating the disease
6
. The 
approach to intercept this interaction of the toxin to the cell could be done in an anti-adhesion 
manner by using carbohydrates to bind with the toxin instead
7
. 
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Figure 1.3: Multivalent protein–carbohydrate interactions at the cell surface (Reproduced with 
permission from reference 8) 
Polysaccharides of glucose, such as glycogen and starch serve as the main form of energy 
storage in animals and plants respectively. In humans, glycogen is made and stored primarily in 
the cells of the liver and the muscles, and functions as the secondary long-term energy storage 
(with the primary energy stores being fats held in adipose tissue). Muscle glycogen is converted 
into glucose by muscle cells, and liver glycogen is converted to glucose for use throughout the 
body, including the central nervous system
9
. In addition, primary and secondary cell walls of 
plants are composed of high amounts of cellulose, hemicellulose and pectin
10
.  
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Polysaccharides and oligosaccharides in biological systems can hence serve a variety of 
functions from being recognition markers for proteins to fine tuning the intrinsic properties of the 
proteins they’re attached to and altering their interactions with other systems11. This necessitates 
further advancements in the study of carbohydrate-protein interactions.  
1.1.2 Role of mannose in biology 
Mannose is a sugar monomer of the aldohexose series of carbohydrates. It is a C-2 epimer of 
glucose and is involved in many biological processes such as toxin mediation. It has also been 
shown to have increased binding when presented in a multivalent manner
12
. Mannose-binding 
receptors are found in a variety of cells including alveolar and splenic macrophages, which 
actively participate in phagocytosis and cell migration and thus have a profound influence on the 
immune response of the host
13
. Certain mannose receptors expressed in hepatic endothelial cells 
internalize glycoproteins that are terminated with mannose via receptor-mediated endocytosis
14
. 
 
Figure 1.4: Chemical structure of D-mannose 
The mannose receptor, a C-type Lectin, found primarily on the surface of dendritic cells and 
macrophages recognises terminal mannose as well as N-acetylglucosamine and fucose residues 
7 
 
on glycans, and is involved in a variety of immunological processes within the body
15
. The 
receptor recognises terminal mannose, N-acetylglucosamine and fucose residues on glycans 
attached to proteins
16
 found on the surfaces of some microorganisms, playing a role in both the 
innate and adaptive immune systems. It also performed additional functions such as the clearance 
of glycoproteins from the circulation, including sulphated glycoprotein hormones and 
glycoproteins to be released in response to pathological events
17
. The mannose receptor recycles 
continuously between the plasma membrane and endosomal compartments in a clathrin-
dependent manner
18
. 
Certain strains of the uropathogenic bacterium Escherichia coli (E. coli) have the ability to 
adhere to epithelial cells in the kidneys and lead to urinary tract infections. This ability is 
mediated by the hair-like appendages on the bacteria, called fimbriae, that are coated with 
carbohydrate-receptors on their surfaces
19
. These receptors are capable of recognizing and 
binding to cell surfaces of the host via adhesion through the carbohydrates expressed abundantly 
on the uroepithelial cells. The adhesion marks the initiation of the infection process
19 
and can 
potentially be blocked, thus successfully preventing the infection, by using certain multivalent 
aryl
20
 and alkyl
19
 mannosides to bind to these protein receptors instead, and hence can serve as 
an alternative therapeutic approach against  bacterial infection. 
1.1.3 Role of α-galactose in biology 
Galactose is a C-4 epimer of glucose which exists in both open-chain and cyclic form as α- and 
-anomers. It has many roles in biological system. Approximately 20% of the oligosaccharides 
on Recombinant Soluble Human CD4 (sCD4) have α-galactose residues present on them11. CD4 
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is a cell-surface glycoprotein found on the mature helper T cells and immature thymocytes, as 
well as on monocytes and macrophages.  
 
Figure 1.5: Structure of D-galactose in its open form and closed α anomer form. 
Certain α-galactose derivatives like galactose-α-1,3-galactose, commonly known as alpha-gal, is 
a carbohydrate found in most organisms’ cell membranes. However, it is not found in primates 
or humans, whose immune systems recognise it as a foreign body and produce xenoreactive 
immunoglobulin M antibodies, leading to organ rejection in cases of transplantation from non-
primate mammals, such as pigs
11
. 
α -Galactosylceramide(α-Gal-Cer;KRN7000) is a biological response modifier which was first  
isolated from an extract of the marine sponge Agelas mauritianus and consists of an α-galactose 
combined with a ceramide structure. α-Gal-Cer (figure 1.6) is a specific ligand for human and 
mouse natural killer T (NKT) cells and was found to exhibit potent anti-tumor activity in murine 
in vivo experiments including a subcutaneous implanted model and metastatic models in the liver 
and lung
21
.  A majority of sugar ceramides found naturally contain β-linkages and have no such 
activities like α-GalCer. 
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Figure 1.6: Structure of KRN7000 
Galactose is also involved in many disease processes. For example, sulfated multivalent 
galactose derivatives have been shown to be potential inhibitors for HIV-1 infections
22
. α-
Galactose based ligands are involved in certain bacterial infections in humans as well.  The 
glycosphingolipid ligand, Gb3, which is present on human epithelial cell surfaces has an α-
galactose terminus which is actively involved in the surface binding with various verotoxins, 
including Shiga and Shiga-like toxins. It is known that infection with verotoxin producing E. coli 
leads initially to hemorrhagic colitis and further to hemolytic uremic syndrome in humans. This 
surface binding interaction is the infection initiating step and can be blocked by availability of 
competing ligands with the same α-galactose functionality. This suggests further exploration in 
the chemical synthesis of such ligands would be a valuable pursuit
23
. 
1.2 Multivalent platforms for carbohydrates 
1.2.1 Lectins as model systems for cell-material recognition 
Lectins are an important class of proteins that interact with carbohydrates in a non-covalent 
manner. They are highly sugar-specific and are upstream initiators of a variety of biological 
processes such as cell adhesion, migration, phagocytosis, cell differentiation and apoptosis
24
. 
They also act as recognition determinants in processes such as the clearance of glycoproteins  
10 
 
from the circulatory system, control of intracellular trafficking of glycoproteins, adhesion of 
infectious agents to host cells, recruitment of leukocytes to inflammatory sites, as well as cell 
interactions in the immune system, in malignancy and metastasis
25
. Lectins are proteins that do 
not have inherent catalytic, antibody-like or enzymatic roles in the body. 
 
Figure 1.7: Lectin receptor-mediated targeting to macrophages (Reproduced with permission from 
reference
 
26) 
The nature of the interactions between lectins and carbohydrates is mainly based on hydrophobic 
interactions and hydrogen bonds between the hydroxyl groups of the carbohydrates and the 
amino-acid residues of the lectin proteins. Metal-ion coordination and hydrophobic stacking of 
patches of sugar surface with the proteins are some other forces responsible for lectin-
carbohydrate binding. The combining sites of lectins are in the form of shallow grooves on the 
11 
 
surface of the protein. Typically, only one or two edges or faces of the carbohydrate ligand are 
bound to the protein
25
. 
One of the striking features of the lectin-carbohydrate interaction is that their binding affinities 
are weak (Ka: 10
3
-10
4
 M
-1
) when the saccharides are in their monovalent forms. In order for the 
interactions between lectins and carbohydrates to be biologically relevant, multiple copies of 
these interactions have to be made either sequentially or simultaneously. For example, an 
increase in binding affinity of about 10
5
 was observed in case of methyl-α-mannoside when a 
synthetic polymer was prepared which displayed multiple mannose residues
27
. 
 
Figure 1.8: The structures of a few branched oligosaccharides and their binding affinities to lectin 
ConA 
While a variety of lectins have been researched in the past, Concanavalin A (Con A) has been of 
major importance, especially for α-D-mannoside residues. It also binds α-D-glucosyl residues. It 
is a member of the legume lectin family. Con A exists in the form of a tetramer at near-neutral 
pH and has one binding site per subunit.  
12 
 
 
Figure 1.9: Cartoon depicting the subunits of Con A and their binding sites (adapted from 
reference 7) 
A variety of assays are commonly used for the evaluation of glycodendrimer binding with 
glycoconjugates. For example, an IC50 can be obtained by labelling Con A with an enzyme and 
adding it to polystyrene wells to which a mannose derivative has been attached. On addition of 
the glycoconjugate, a concentration profile required to inhibit binding of this Con A to the wells 
can be generated giving insights into the binding affinities of the glycoconjugate
29
. Receptor 
clustering assays, including precipitation and turbidity assays, involve the formation of insoluble 
aggregates of Con A with the dendritic ligand, and these assays can provide data concerning the 
kinetics and stoichiometry of binding
30
. The hemagglutination assay is one of the widely used 
assays used for characterizing glycoconjugates-Con A binding. This assay can compare the 
relative binding affinities of various monovalent or multivalent mannoside-based ligands. Con A 
13 
 
interacts with glycoproteins found on the surfaces of red blood cells and causes their 
agglutination or aggregation. This agglutination is inhibited by the above mentioned mannoside-
based ligands by their binding to the lectin instead. The comparison of the minimum 
concentration of ligands required for the agglutination inhibition can lead to insights into their 
relative binding affinities. 
1.2.2 Multivalency in carbohydrates 
Multivalency is found widely in nature. For example, a gecko’s foot has millions of spatula-
shaped setae arranged in lamellae, which help it adhere to practically any surface by creating a 
strong resulting attractive force from millions of Van der Waals interactions of small magnitude 
from each seta. In a similar fashion, multivalency in carbohydrate interactions with proteins and 
microbes is of major importance. It has been shown that the clustering of carbohydrates on a 
multivalent architecture significantly increases the binding affinity of these interactions
27
 via the 
mechanisms of the chelate effect as well as receptor clustering or the proximity effect, whereby 
the local density of the ligands increases due to clustering, resulting in efficient binding. This 
effect was first noted by Lee and co-workers
31
 and has found a wide range of applications in 
biology and medicine, proving to be an important tool for biotechnological and therapeutic 
purposes. By clustering ligands, their topological and spatial proximities can be tuned and the 
optimal molecular features can be identified, leading to increased binding affinities
28
. 
14 
 
 
Figure 1.10: The three likely binding motifs and their expected relative activities for the interaction 
of glycodendrimer with Con A (Reprinted with permission from Reference 29. Copyright 2001 
American Chemical Society.) 
There are a variety of multivalent platforms that have been used in order to depict multivalency 
for carbohydrates. These include, for example, polymers, nanoparticles, dendrimers, vesicles and 
proteins. 
Proteins: Carbohydrate epitopes can be attached to the surfaces of proteins through chemical or 
enzymatic methods with the help of reactive groups in the side chains of proteins. A number of 
examples
32, 33 
of carbohydrate attachment to Bovine Serum Albumin (BSA) carrier protein have 
been reported. In order to identify the effects of varying the number of sugar residues on the 
binding affinities to a lectin, a competitive inhibition assay was employed, wherein the inhibition 
of the binding of a chosen glycoprotein receptor to its lectin by the synthetic neoglycoprotein 
was tested. The studies demonstrated that the binding affinities increased with increasing sugar 
content in the neoglycoprotein, thereby establishing the effect of increasing valencies and the 
logarithmic increases in binding affinities
33
. However, in large carrier proteins, the spatial 
disposition of individual sugar ligands on the proteins is not very well identified because of their 
15 
 
overall complex nature. Additionally, the use of proteins as carriers might lead to non-
carbohydrate-specific interactions during biological analysis, which essentially hinders structure-
property relationship attribution.
34 
Vesicles: Polymer vesicle is yet another architecture that has been used for sugar-scaffolding. 
Amphiphilic block copolymers can self-assemble in solution into vesicles with a structure 
analogous to that of phospholipid vesicles
35
. When mixed with a suitable solvent such as water, 
the hydrophobic blocks of the polymer amphiphiles associate to form the core of the membrane 
while the more hydrophilic blocks are exposed to the interior and exterior solution. The surfaces 
of these vesicles can be functionalized with carbohydrates. For example, Gillies et al. 
functionalized poly(butadiene-block-ethylene oxide) (PDB-PEO) vesicles with dendritic 
mannose at the periphery
35
. It was demonstrated that the functionalized vesicles showed 
enhancement in binding affinity to lectins by 1-2 orders of magnitude relative to the non-
dendritic vesicle system. In another example, a multifunctional polymer vesicle system with 
polyester dendrons functionalized with N-Acetylneuraminic acid (Neu5Ac) was synthesized
36
. It 
was found that while the sialodendron exhibited a 17-fold enhancement (per sialoside) relative to 
the small molecule, the dendritic sialopolymersomes resulted in an almost 2000-fold 
enhancement in binding affinity
36
. 
Nanoparticles: In order to explore various scaffolds for carbohydrate ligand representation, 
nanoparticles were used as carriers for a variety of sugar residues. Jain et al. developed the 
mannosylated gelatin nanoparticles for targeted delivery of an anti HIV drug, didanosine
37
. The 
authors synthesized the nanoparticles by a two-step desolvation technique and mannose was 
coupled to the surface amino groups of gelatin nanoparticles. In cellular uptake studies mannose-
coupled nanoparticles showed increased uptake by the lung, liver and lymph nodes compared to 
16 
 
uncoupled gelatin nanoparticles and free drug. In yet another example, gold nanoparticles with α-
acetal-poly(ethylene glycol) layers were functionalized with β-D-lactopyranoside and their 
aggregation behavior towards Recinus communis agglutinin (RCA120), a bivalent lectin selective 
to galactose, was studied. The aggregation of the lactose-functionalized gold nanoparticles by the 
RCA120 lectin was found to be reversible, recovering the original dispersed phase and color by 
addition of excess galactose
38
. 
 
Figure 1.11: Synthesis of sugar-functionalized gold nanoparticles (adapted from reference 28) 
Polymers and polymer assemblies: Polymers are considered excellent models for binding 
carbohydrates owing to their vast scope of pendant functionalities. They are relatively cheaper 
and easier to synthesize, purify and characterize on a small to large scale compared to the 
previously discussed models. A study involving a polymethacrylate functionalized with 
galactopyranoside pendant units and peanut agglutinin lectin showed that the glycopolymer 
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exhibited approximately 50 times better binding affinity when compared to the monovalent 
sugar
39
. Recently, ring-opening  polymerization  (ROP)  and copper-catalyzed alkyne-azide 
cycloaddition “click” reaction  were  used  to  prepare  a  series  of  amphiphilic block-graft  
(poly-α-azidecaprolactone-graft-sugar)-b-polycaprolactone  polymers and their self-assembly as 
well as cytotoxicity was studied
40
. In this context, Kiessling et al. have largely exploited ring-
opening metathesis polymerization (ROMP) to generate multivalent ligands based on dextran, 
ficoll, or polyacrylamide derivatives with a variety of recognition elements including 
carbohydrates at their termini
41
. Sialic acid- or neuraminic acid-appended polyvalent polymers 
were subjected to a series of studies. Whitesides and co-workers used polyacrylamides as 
scaffolds for pendant α-sialoside groups. This strategy is based on polyvalent polymeric 
inhibitors able to compete with the polyvalent virus-cell interaction. The studies were focused 
primarily on the inhibition of the viral hemagglutinin binding to the erythrocytes by synthetic 
polymers bearing sialosides
42
. Although polymers provide tremendous multivalent 
functionalities, the exact quantitative characterization of sugar groups attached per mole of the 
carrier is rather ambiguous. 
1.3 Dendrons and dendrimers 
1.3.1 Introduction 
Dendrimers and dendrons represent a unique class of macromolecules that has recently attracted 
increasing attention from both academia and industry. They are highly-branched macromolecules 
with well-defined, 3-dimensional architecture. As a hierarchical structure, dendrimers are made 
up of three structural regions: a) a core b) layers of branching repeat units comprising the 
backbone, each layer termed a generation, and c) end groups on the periphery (figure 1.12). The 
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interior part of the dendrimer structure is suitable for guest encapsulation purposes, given that it 
is safely protected from the surroundings by the dendritic layers. ‘Dendrons’ have a wedge-like 
structure and emerge from a monovalent core moiety called the focal point. In such molecules, 
conjugation from the periphery and/or focal-point may result. Each generation of these 
macromolecules results in an increase in the overall diameter as well as in the number of end 
groups. Since the increase in the number of end groups is exponential, different generations 
differ in rigidity as well as density and may assume an increasingly globular shape at higher 
generations
43
. 
 
Figure 1.12: Schematic representation of the architectural differences between a) linear, b) 
hyperbranched, and c) dendritic polymers (Reprinted with permission from reference 44. 
Copyright 2002 American Chemical Society) 
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Figure 1.13: Schematic of a dendrimer and dendron structure (Reproduced with permission from 
reference 45) 
It was in the early 1980s that dendron and dendrimer synthesis first gained significant interest 
when Tomalia et al
46
 followed by Newkome et al
47
 described successfully synthesized 
poly(amidoamine) (PAMAM) and arborol dendrimers respectively. Since then, over 100 
different structure of dendrimers have been reported
48
. 
The two striking features of these macromolecules are their monodispersity and their 
multivalency. The synthesis of dendrimers is highly iterative and except for some minor defects 
in the structure in higher generations such as incomplete growth of the dendrons, the number of 
functionalizable end groups on the periphery can be well-controlled, giving dendrimers their 
unique monodispersity. In biomedical applications, such as carbohydrate-protein interactions, 
monodispersity is a promising tool as it gives a very good control on the number of ligands 
attached to the periphery, thus enabling a better understanding of the structure-property 
relationship of the bonded system
43
. Additionally, the multivalent nature of their peripheries 
allows for a scaffold for these ligands, which in a variety of cases has been shown to increase the 
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binding affinities of ligands to their receptors via the multivalent effect
35
. In addition to these 
properties, the covalent nature of bonds in dendrimers and dendrons eliminates the need for the 
achievement of thermodynamic equilibrium that is needed for self-assembled structures, making 
it a more stable choice for multivalency
44
 and their overall globular shape gives rise to 
interesting architecture-dependent properties in solution
49
. 
Because of the above quoted properties of dendrimers, they have proven their significance in 
boosting the solubility as well as bioavailability of drugs
50
, DNA derivatives, and 
carbohydrates
51
 and have helped in increasing the in vivo circulation times of contrast agents
52
. 
However, in order to tackle the toxicity challenges associated with use of dendrimers in a 
biological setting, the use of dendrimers with biodegradable cores and branches has been of 
increasing focus. The approach to the production of such dendrons is through including 
monomers that are metabolic products of various biological pathways. The resulting dendrimers 
are required to be water-soluble, non-toxic, non-immunogenic and capable of crossing 
appropriate biological barriers. In this regard, polyester dendritic systems are of utmost 
importance. Dendrimers based on 2,2-bis(hydroxymethyl)propionic acid (Bis-MPA) have proved 
promising in clinical trials for the delivery of doxorubicin, paclitaxel, camptothecin, and 
diammineplatinum (anticancer agents)
43
. 
 
1.3.2 Chemical synthesis of dendrimers and dendrons 
There are two main strategies for the synthesis of dendrimers, the divergent and the convergent 
methods. The divergent method of dendrimer/dendron synthesis
46
 is an inside out approach 
wherein the synthesis is initiated at the core or focal point and the macromolecule is built up 
through each layer or generation to the periphery. In the convergent approach
53
, the synthesis 
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initiates at the periphery which is bound together to the required number of generations and later 
coupled to the core.  
The divergent approach is typically used for the large scale synthesis of dendrimers as the 
quantity increases with every generation. It however has the limitation of time-consuming 
protection and deprotection reactions that have to be done for the iterative synthesis. Moreover, 
in higher generations, reaction incompletion, and hence defects in the structure of dendrimers 
poses a problem.  
On the other hand, convergent synthesis reduces the number of defects in the structure as it 
involves coupling of individual pieces of the macromolecule, making it a better choice in the 
scenario where monodispersity is of utmost importance. The convergent approach can also 
potentially be used to synthesize in a controlled manner an asymmetric dendrimer structure with 
multiple different kinds of dendrons attached at the core. This approach, however, suffers from 
problems involving steric hindrance for coupling in higher generation dendrons and decrease of 
overall mass in each step, making it non-ideal for large scale synthesis.  
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Figure 1.14. Comparison of the (a) divergent and (b) convergent approaches to dendrimer 
Synthesis (Reproduced with permission from reference 45). 
 
1.3.3 Carbohydrate-dendrimer conjugates 
The need for a detailed study of carbohydrate-protein interactions at a molecular level is 
essential, as evident from the multitude of scenarios where such interactions are involved, 
including cell adhesion, infection initiation, cancer metastasis etc. The clear understanding of 
such processes is only possible through development of structurally well-defined model systems 
and macromolecules that can be synthesized, purified, characterized and analyzed for their 
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biological activity
34
. As described in section 1.2.2, there are a variety of scaffolds available and 
they have been researched upon in the context of multivalency of carbohydrates. Among these, 
dendrimers have emerged to be a yet another class of molecules, as in addition to improving the 
valency of the sugars, their well-defined structure eliminates limitations over heterogeneity of 
the resulting structure.  
Different generations of dendrimers provide a choice in further tuning of the valency as well as 
the size of the macromolecule. By changing the kind of dendrimers used, their linkages to the 
carbohydrates can be experimented upon. A wide range of saccharides including mannose, 
galactose, glucose, lactose, maltose, xylose, Neu5Ac (sialic acid), and other oligosaccharides 
have been conjugated to various dendrimer peripheries via different linkages such as amide, 
hydrazide, amine, thioether, thriourea, and triazole linkages. For example, Peiters et al. 
synthesized dendrimers based on 3,5-di-(2-aminoethoxy)-benzoic acid repeat unit with alkyne 
functional groups at their periphery and conjugated them with azide-terminal mannose with the 
help of a copper-catalyzed alkyne-azide cycloaddition “click” reaction to yield glycodendrimers 
functionalizable to a chip surface to make a microarray
54
. In yet another example, Thompson and 
Schengrundhave successfully displayed GM1 pentasaccharide ligands for the E. coli heat-labile 
toxin on a poly(propylene) amine dendrimer using an amine-isothiocyanate coupling reaction
55
. 
Cloninger and coworkers have prepared mannose functionalized PAMAM dendrimers ranging 
from the 1
st
 to 6
th
 generation and their binding affinities to Con A were shown to depend on the 
sizes and multivalencies of the bioconjugates
29
. Moreover, they were able to systematically 
control the degree of lectin clustering and overall activity by varying the mannose/hydroxyl 
ratios on the surfaces of 3
rd
 to 6
th
 generation dendrimers
56
. 
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Roy et al. prepared nanometer-sized, water-soluble glycodendrimers (mannose-functionalized 
poly(amidoamine)) (PAMAM) generation G0 cystamine core dendrimer) coated gold 
nanoparticles
57
 (figure 1.15). The binding constant of Con A to the gold-mannose interactions 
was found to be 100 times higher than the binding constant values obtained in the interactions 
with the glycodendrimer alone
57
. Similarly, McReynolds et al. evaluated the feasibility of 
synthesizing six sialic acid-PAMAM glycodendrimers using unprotected sialic acid and amine 
terminated PAMAM dendrimer
58
. Compounds that showed promising binding characteristics 
were then further assessed for inhibition of HIV-1 infection using a well-characterized luciferase 
reporter gene neutralization assay
58 
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Figure 1.15: Gold nanoparticle functionalized with mannose terminal glycodendron (Reproduced 
with permission from reference 57) 
 
The use of glycodendrimers as ligands, although attractive in the scheme of homogeneity and 
multivalency, needs a thorough optimization of the choice of dendrimer backbone as well as 
generation. In lower generations of the dendrimer, because of low valency, the binding affinities 
may not vastly improve in comparison to monovalent saccharides. On the other hand, steric 
factors including crowding of ligands at the periphery of dendrons at higher generations may 
lead to their incomplete binding to the receptors
7
. 
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1.4. Linear-dendron hybrids 
Linear-dendron hybrids are a relatively new class of block copolymers that have gained 
significant interest in the past years. They are composed of fragments of polymers and perfectly 
branched dendritic entities that are fundamentally different from each other in architecture. The 
linear nature of the polymers contrasts with the globular architecture of dendrimers to give rise to 
interesting properties exclusive to neither of the two constituents.  
 
 
Figure 1.16: The resultant structures formed through self-assembly. (Reproduced with permission 
from reference 59) 
There are three principal synthetic routes that are popular for synthesis of such hybrids
60
: 
a) Coupling of individual linear and dendritic blocks. 
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b) Divergent growth of dendrons on the polymer 
c) Use of dendrimers as macroinitiators for polymerization of linear chains. 
Such amphiphilic hybrids undergo ‘microphase separation’ in solution and generate interesting 
self-assembled morphologies. These assemblies are driven by various weak, non-covalent forces 
and can effectively entrap drug molecules in their voids. The increase in entropy due to 
aggregation of hydrophobic part and exclusion of water plays an important role in driving these 
structures to form. These structures offer an attractive alternative to traditional drug carriers
59
. 
They solubilize and protectively encapsulate the drugs and control their release into specific 
desired locations minimizing frequency and concentrations for target-specific delivery. Recently, 
there has been an increasing interest in such self-assembled amphiphilic structures because of 
their applications as drug-encapulating materials as well as their bioactive outer membranes
61
. 
Some examples of self-assembled molecules include poly(ethylene glycol)-block-
poly(ε−caprolactone)(PEG-PCL) micelles that have been used to form micelles capable of 
encapsulating small drugs like paclitaxel and rapamycin
62
. In yet another example, vesicles made 
by using two distinct diblock copolymers were able to solubilize doxorubicin as well as 
paclitaxel in their aqueous lumen and hydrophobic walls respectively and the shrinkage of tumor 
cells in mice was more compared to when no carrier was used
63
. 
Additionally, in the field of tumor cell targeting, such nano-sized, drug-encapsulating systems 
can be used to address some of the major challenges of drug-delivery systems such as selectivity. 
In order for tumor cells to rapidly grow, they must stimulate the production of blood vessels. Due 
to the rapid growth and corresponding angiogenesis of tumor cells, they have leaky architecture 
and wide fenestrations
64
. These cells also lack an efficient lymphatic system. Because of these 
properties, tumor blood vessels show high permeability to macromolecules and nano-sized 
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particles and their retention is prolonged by tumor cells
64
. This phenomenon is known as 
Enhanced Permeability and Retention (EPR) effect.  
General guidelines for designing such delivery vehicles include use of molecules that are 
biocompatible, have minimum cytotoxicity and are efficiently degradable by the body after 
delivery
65
. In this regard, linear dendron hybrids with glycodendrons as the hydrophilic block 
and a polypeptide such as poly-γ-benzyl-L-glutamate (PBLG) as the hydrophobic block can be 
hypothesized to self-assemble into some interesting structures. These systems with carbohydrates 
on the surface would have an additional benefit in biorecognition for target-specific drug 
delivery to cells. They are structural mimics of natural glycoproteins and possess the advantage 
of having a well-defined secondary structure allowing ordered display of carbohydrate moieties.  
 
1.5 Dendronized Polymers 
Dendronized polymers (or denpols), as the name suggests, are analogues of the above discussed 
dendrimers, where these dendrimers of various types and generations are displayed on a long, 
linear, polymeric backbone, as grafted pendant groups. There are several aspects of dendronized 
polymers that can be examined: 
1. Overall l/d ratio and rigidity: Denpols are made up of a one-dimensional polymeric chain 
combined with more globular dendritic wedges, providing these macromolecules with interesting 
properties. The rigidity of these structures has been hypothesized to be dependent on the density 
and generation of the dendrons grafted. In case of high steric repulsions between higher 
generation and more densely packed dendrons this leads the overall structure to be rigid and rod-
like, while the chain flexibility is much more relaxed otherwise, and the structure can be bent and 
coiled. In both these extreme cases, the overall length to diameter ratio increases drastically with 
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increasing rigidity. The length of these molecules can also be tuned by choosing the backbone of 
appropriate size and the distance between adjacent grafted groups can be varied as well. 
2. Multivalency: Owing to a large number of pendant groups on one molecule of the denpols, the 
scope of end-group functionality of these structures is tremendous. For example, on a polymer 
with 20 repeating monomeric units grafted with a dendron with 8 peripheral groups per unit, 160 
sites of further end-group attachment is possible, making these molecules one of the richest 
sources for multivalent applications.  
 
Figure 1.17: Cartoon representation of a coiled polymer backbone’s stretching through the 
attachment of increasingly sterically demanding dendrons. Polymer backbone with a) no dendrons; 
b) first generation dendrons; c) second generation dendrons; d) third generation dendrons 
(reproduced with permission from reference 66) 
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There are three main synthetic approaches to make dendronized polymers
67
: 
1. In the ‘graft-to’ approach, the dendritic entity of appropriate generation and the polymer 
backbone are synthesized individually, and then later connected to make the denpols. This 
approach offers the maximum control on the dendritic functionalization, but suffers from 
incomplete coverage of the backbone because of steric effects during conjugation to the 
polymers. 
2. The ‘graft-from’ approach, on the other hand, includes synthesis of the dendritic entity from 
the polymer backbone via a stepwise growth process. This method ensures increased density of 
pendant groups on the polymer comparing to the ‘graft-to’ way, but may lead to synthetic 
difficulties leading to defects in dendron structures.  
3. The ‘macromonomer’ approach includes polymerization as the last step in synthesis, whereby 
the monomer is conjugated with the dendron beforehand. This approach gives the benefit of each 
unit having the perfect dendronization as well as full coverage of the polymer backbone. Yet 
another advantage is the possibility of dendrons of different types and generations grafted on the 
same polymeric chain. However, dendrons of higher generation suffer from low degree of 
polymerization and hence fewer pendant groups per polymer molecule. 
Extremely long dendronized polymers with polystyrene as the backbone and two trimethlysilyl 
ethyloxy carbonyl (Teoc) protected peripheral amine groups dendrons of generation 4 were 
synthesized by Schluter et al
68
 (figure 1.18)., and their individualization and atomic force 
microscopy (AFM) visualization on graphite, and its manipulation with the AFM tip were 
reported. Seeberger et al. reported biocompatible glyco-dendronized poly-L-lysine (PLL) 
polymers that carried either three or nine mannose- or galactose-bearing dendrons
69
. These 
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glycodendronized polymers were capable of providing a platform for studying the carbohydrate-
pathogen binding interactions as well as for biosensor applications for mannose-binding E. coli. 
 
Figure 1.18: Generation 4 polystyrene dendronized polymer (Reproduced with permission 
from reference 68)  
Although a number of examples of dendronized polymers of various polymeric backbones and 
different generations and kinds of dendrons have been reported, to the best of our knowledge, 
lectin binding properties of ultra-high multivalency glyco-denpols have not been explored. 
 
1.6 Scope of the thesis 
The overall goal of the thesis is the synthesis of glycodendrons consisting of a 2,2-
bis(hydroxymethyl)propionic acid (bis-MPA) backbone with peripheral α-mannose and α-
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galactose derivatives, and the conjugation of these dendrons to linear polymers to form highly 
multivalent carbohydrate-based ligand systems.  
The first goal is to conjugate glycodendrons to a functionalized linear polymer backbone to 
create glyco-denpols. Despite many systems having been developed as models for multivalency, 
dendronized polymers that combine the globular structure of dendrons with the linear structure 
of linear polymers have not been previously studied upon in the context of carbohydrate-protein 
recognition. In addition to studying the effect of multivalency, comparing different lengths and 
generations of dendronized polymers help with the understanding of the effect of rigidity of these 
systems on their binding ability, which has not previously been done for such glycodendrons.  
 
Figure 1.19: Second generation dendronized polymer with mannose end-groups 
 
The second goal of this thesis is to use these glycodendrons and covalently attach them to 
polypeptides such as PBLG to make an amphiphilic linear dendron hybrid system capable of 
self-assembling in aqueous solution.  These self-assembled structures are novel as they combine 
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the effects of multivalent presentation of carbohydrates with self-assembly properties of 
amphiphilic copolymers all in a single scaffold, thereby avoiding the necessity of surface 
functionalization steps.  
 
Figure 1.20: Model reaction scheme for synthesis of linear dendron hybrids and their self-assembly 
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Chapter 2 
2 Results and Discussions 
2.1 Synthesis of glycodendrons 
2.1.1  Synthesis of Amine-functionalized Polyester Dendrons of Generations 1, 2, 3 and 4 
A library of 4 generations of dendrons was developed in order to compare the effect of size and 
valency in the final macromolecules. Amine groups were selected for the peripheries of the 
dendrons as they are ideal functional handles for further derivatization with the carbohydrates. 
The preparation of the amine-functionalized dendrons was done in two synthesis phases wherein 
the respective hydroxyl-terminated dendrons were synthesized first using the previously reported 
procedure
70
, and then an additional linker was added to them using protected β-alanine through a 
hydroxyl-carboxylic acid coupling reaction.  
For this synthesis, a polyester dendron based on Bis-MPA was selected due to its ease of 
synthesis and biocompatibility
71,44
. Bis-MPA-based dendrimers have shown promise in clinical 
trials for the delivery of doxorubicin, paclitaxel, camptothecin, and diammineplatinum, which 
are all anticancer agents
43
. They can be prepared iteratively through protection and deprotection 
reactions using both convergent and divergent approaches
7
. The divergent approach
35
 was 
selected as the experience in the group has been that this method results in easy purification and 
good yields. An alkyne focal point was selected as the starting point for the dendron synthesis 
since it allows for the post-synthetic conjugation to various terminal azides by a copper-
catalyzed alkyne-azide cycloaddition “click” reaction 72.  
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The polyester bis-MPA based anhydride 2 (scheme 2.1) was first prepared by the N,N’-
dicyclohexylcarbodiimide (DCC) coupling reaction of the acetonide protected bis-MPA 1. The 
first generation dendron 4 was prepared by the coupling of propargyl alcohol to anhydride 2 
using a standard coupling reaction in presence of 4-(dimethylamino)pyridine (DMAP) as a 
catalyst (scheme 2.1). The reaction was monitored by thin layer chromatography for the 
complete disappearance of the spot corresponding to propargyl alcohol. The crude dendron after 
removal of the catalyst and pyridine was purified by column chromatography to remove 
byproducts such as residual anhydride and protected bis-MPA. Deprotection of the acetonide 
groups with H2SO4/MeOH was performed to give the deprotected first generation (G1) dendron 
5. 
The coupling to anhydride 2 and deprotection was repeated iteratively to provide the second, 
third and fourth generation dendrons 7, 8 and 9 with four, eight and sixteen available sites for 
functionalization respectively. The reactions were monitored via 
1
H NMR spectroscopy and thin 
layer chromatography. It was essential that all the end-groups of the dendron undergo complete 
functionalization since the removal of incompletely functionalized dendrons was very difficult 
owing to their similarity in structure and polarity. The purification was performed at the 
protected dendron stage for each generation to remove unreacted starting materials and 
byproducts. The dendrons were very stable and could be stored in the deprotected form in the 
fridge at 4 C temperature over several months with no change in their respective 1H NMR 
spectra. These hydroxyl terminated dendrons 5, 7, 8 and 9 were previously reported and their 
characterization data agreed with those previously reported
61
. 
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Scheme 2.1: Synthesis of hydroxyl-terminated dendrons of generations 1 through 4 
In the second phase of the synthesis process, dendrons 5, 7, 8 and 9 with peripheral hydroxyl 
groups were further functionalized by introducing peripheral amine moieties. Based on previous 
work from our group
72
, it was determined that the addition of a β-alanine shell would provide the 
desired amines. The carboxylic acid of β-alanine was used to functionalize the prepared 
dendrons. A t-butyl carbamate (Boc) group was used to protect the amine group of the amino 
37 
 
acid during the coupling reaction as it would otherwise be a competing nucleophile in the 
reaction. Boc groups are very common amine protecting  groups because of their easy removal 
by trifluoroacetic acid (TFA).  Hence, the peripheral groups were converted to protected amines 
by reacting them with Boc protected β-alanine 11 using a 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) coupling reaction in presence of DMAP to give the 
protected dendrons 11, 13, 15 and 17 (schemes 2.2-2.5). Previously in our group, this reaction 
has been done via an anhydride derivative of boc-protected β-alanine24 using DCC as the 
coupling agent. This approach however suffered from the difficulty in removal of the reaction 
by-products (N-acylurea and dicyclohexylurea) in organic solvents owing to their partial 
solubility. The byproducts generated by EDC (figure 2.1), however, are water soluble, because of 
which they are easily removable by acidic and basic water washes without the need of time-
consuming chromatography procedures, thus making the synthesis more efficient and increasing 
yields.  
 
Figure 2.1: Difference in structure of DCC and EDC coupling reagents. 
 
  
38 
 
 
Scheme 2.2: Synthesis of the amine-terminated generation 1 dendron 
 
 
Scheme 2.3: Synthesis of the amine-terminated generation 2 dendron 
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Scheme 2.4: Synthesis of the amine-terminated generation 3 dendron 
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Scheme 2.5: Synthesis of the amine-terminated generation 4 dendron 
The generation-3 boc-protected dendron 15 has been previously reported
72
 and the spectral data 
of this molecule was consistent with the literature values. The generation 1, 2 and 4 dendrons 
(11, 13 and 17) are new molecules and have been characterized with 
1
H Nuclear magnetic 
resonance (NMR) spectroscopy, 
13
C
 
NMR spectroscopy, Infrared (IR) spectroscopy and Matrix-
assisted laser desorption/ionization (MALDI) spectrometry.  
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Figure 2.2: MALDI spectrum of amine functionalized generation 2 dendron 13 
 
Figure 2.3: 
1
H NMR spectrum of dendron 13 (CDCl3, 400 MHz) 
The quantification of linker groups attached per hydroxyl dendron could be easily done by 
integrating the respective peaks in the 
1
H NMR spectra. The conversion was found to be 
quantitative for all the four generations. The major peaks in the following MALDI spectra are 
consistent with the expected molecular weights of the corresponding dendrons (figure 2.2). The 
MALDI spectrum of the generation 4 boc-protected dendron 17 did not show any peaks near the 
theoretical molecular weight, possibly because of the disintegration of the molecule during 
Calculated: [M + Na
+
]: 1111 
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ionization. The large number of boc-groups on the surface of the molecule are highly labile, 
particularly in the presence of acidic MALDI matrices, and hence sensitive to degradation.  
These dendrons were then deprotected using TFA in dichloromethane (DCM) to remove the boc 
group and provide the unprotected dendrons 12, 14, 16 and 18 respectively, which were then 
ready for conjugation to the desired target surface groups. Dendron 16 has been previously 
characterized
72
 and the other generations were characterized as described above. For example, 
figure 2.4 shows a MALDI of the generation 2 dendron 14.  
 
Figure 2.4: MALDI spectrum of amine functionalized dendron 
 
2.1.2 Synthesis of an Isothiocyanate-Functionalized Mannose Derivative   
As described above, mannose was chosen as the carbohydrate entity of interest for the 
preparation of the multivalent dendronized polymers. In particular, it was selected as a model 
biological ligand, as its multivalent binding to targets such as Con A has been extensively 
Calculated: [M + Na
+
]: 712 
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investigated and a number of assays, including the hemagglutination
73
 and turbidity
74
 assays, 
have been used to elucidate the relative binding affinities and binding rates of different 
multivalent mannose ligands
75
. Our group has previously been successful in functionalizing the 
peripheral groups of third generation amine-terminal polyester dendrons using isothiocyanate 
derivatives of sugars
35,36
. Hence, an isothiocyanate functionalized mannose was targeted.  
As shown in scheme 2.6, mannose was first globally protected using acetic anhydride and 
DMAP in pyridine to provide 20 as a 0.8:1 mixture of α and β anomers as determined by 1H 
NMR spectroscopy. In order to introduce a linker, a glycosylation reaction with an alcohol was 
chosen. 2-Azidoethanol was prepared separately by refluxing sodium azide in 2-bromoethanol 
for 2 days at 100 °C. Water and ethanol were removed by distillation and it was stored over 
activated molecular sieves until required. It was then reacted with the protected mannose 
derivative 20 in the presence of freshly distilled boron trifluoride etherate (BF3Et2O) as a Lewis 
acid to selectively glycosylate the sugar from the bottom face through the anchimeric assistance 
of the C-2 acetate. The reaction was monitored by shifting of the peak corresponding to the 
anomeric proton in the 
1
H NMR spectrum. The rate of reaction of the two anomers of the starting 
material was observed to be unequal as the peak corresponding to the β-anomer was slow to 
disappear. Nevertheless, the reaction mixture was stirred with the addition of extra catalyst until 
the complete disappearance of the starting material peak.  
44 
 
 
Scheme 2.6: Synthesis of isothiocyanate-functionalized mannose derivative  
The azide derivative 21 was then deacetylated in basic medium using sodium methoxide in 
methanol to yield the deprotected sugar 22. The azide product was finally reduced using Pd/C 
and H2 in methanol to yield the amine 23.  
Treating the amine with thiophosgene gave the desired isothiocyanatoethyl-α-D-
mannopyranoside 24. In the early synthetic attempts for the conversion of the amine derivative 
23 to the isothiocyanate derivative 24, it was noticed that the product conversion was very low. It 
was concluded that the reaction did not go to completion because of the acidic environment 
generated by the byproduct HCl and that the conversion of amine to isothiocyanate requires basic 
medium. A tertiary amine N,N-diisopropylethylamine (DIPEA) that does not hinder the reaction 
in any way while neutralizing the byproduct was selected. To avoid hydrolyzing the anomeric 
group of the mannose, the pH was maintained around 8.5-9 for the entire reaction time.  
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 The reactions were primarily monitored via the shifting of the anomeric proton as well as 
protons corresponding to the side chain of the sugar, by 
1
H NMR spectroscopy. The reaction 
product was lyophilized to remove water; however, no further purification was done to remove 
the DIPEA-HCl salt and the dry product was taken to the next step directly. This product was 
further characterized via 
1
H NMR spectroscopy and electrospray-ionization (ESI) mass 
spectrometry to ascertain the presence of the isothiocyanate derivative in the mixture and the 
proton shifts and the molecular weight was consistent with the expected value. The amine 
derivative was stored under argon at -4 C and converted to isothiocyanate as needed given the 
instability of the isothiocyanate and its tendency to dimerize.  
2.1.3 Conjugation of Isothiocyanate-Functionalized Mannose to Dendrons  
The first through fourth generation dendrons 12, 14, 16 and 18 were conjugated via an 
isothiocyanate-amine coupling reaction
35
. Excess base DIPEA was added to the reaction mixture 
in order to deprotonate the amine groups of the dendron as well as to neutralize any trace amount 
of TFA from the boc deprotection of the dendrons. 2.0 equivalents of the mannose derivative 24, 
per amine group of the dendron, were then added as a solution in dry N,N-dimethylformamide 
(DMF) and the reaction was performed in a moisture-free environment for 36 hours.  
The first generation dendron 25 could not be purified using dialysis owing to the small size of 
the molecule. Chromatographic techniques were unsuccessful as well due to failure in 
establishing a solvent system that lead to an appropriate separation between the impurities and 
the product. 
For the 2
nd
 and 3
rd
 generation dendrons 26 and 27, excess starting materials, possible urea dimers 
of 24, as well as DIPEA were removed by dialysis in DMF, using a 1000 g/mol molecular 
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weight cutoff (MWCO) dialysis membrane for 48 hrs and then in water for 6 hours using the 
same membrane. The fourth generation dendron 28 was characterized so far using 
1
H NMR and 
13
C NMR spectroscopy with further characterization to follow in the future work. 
 
Scheme 2.7: Synthesis of mannose functionalized dendrons of generation 2, 3 and 4 
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2.1.4 Synthesis of an Alkyne functionalized Mannose Derivative  
In order to compare the dendritic architecture on the dendronized polymer with a non-dendritic 
one, a mannose derivative that could be conjugated directly to the polymer was also synthesized. 
To achieve this, a glycosylation reaction was done on fully-protected mannose 29 with propargyl 
alcohol as the nucleophile and BF3Et2O as the Lewis acid in dry conditions. The resulting 
products 30 and 31 have been previously reported
76
 and were characterized by 
1
H NMR 
spectroscopy with the data corresponding well with the reported values. 
 
Scheme 2.8: Synthesis of alkyne functionalized Mannose Derivative 
2.1.5 Conjugation of Isothiocyanate-Functionalized Galactose to Dendrons  
The polyester dendrons 14, 16 and 18 with peripheral amine groups were functionalized with an 
α-D-galactose derivative 32, linked to a terminal isothiocyanate group. This derivative was 
synthesized by Dr. John Trant in the Gillies group as a C-linked derivative of galactose. A 
carbon-linkage to the sugar makes the glycosylated product highly stable to hydrolysis as 
compared to an oxygen linkage. 
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Figure 2.5: C-linked isothiocyanate derivative of α-D-galactose 
This galactose derivative was then conjugated to the dendrons via the amine-isothiocyanate 
reaction described above in presence of an organic base DIPEA. As shown in scheme 2.9, second 
(33), third (34) and fourth (35) generation glycodendrons were isolated after dialysis. 
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Scheme 2.9: Synthesis of galactose functionalized dendrons of generation 2, 3 and 4 
2.2 Applications of glycodendrons 
These glycodendrons with well-defined multivalent architecture and a multiple carbohydrate 
groups displayed on the periphery can be further utilized for a variety of applications. 
Physiologically relevant affinities of lectins are generally reached only when multivalent 
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interactions are achieved and for this the above-mentioned glycodendrons can potentially be used 
to study carbohydrate-protein interactions that are implicated in many intercellular events
77
. 
These glycodendrons are also hydrophilic in nature owing to multiple hydroxyl groups at their 
surface and on coupling with a hydrophobic entity (such as a polypeptide), they have the 
potential to generate interesting self-assembled molecules in appropriate solvents. A few 
applications of these glycodendrons are listed in the following sections. 
2.2.1 Ultra-high multivalency dendronized polymers  
In order to greatly increase the number of carbohydrate units displayed on a scaffold, these 
glycodendrons of different generation were grafted on to a linear polymer backbone to yield 
ultra-high multivalency dendronized polymers. For this purpose, a linear polycaprolactone (PCL) 
chain was selected. PCL is a well-known biodegradable polymer that is currently FDA approved 
for uses in tissue engineering
78
 and drug delivery
79
. As an aliphatic polyester, this polymer can 
be hydrolytically and/or enzymatically degraded into easily metabolized products in the body, 
and hence is anticipated to be a biocompatible choice for biomedical applications
80
. 
2.2.1.1Synthesis of poly(α-azido-ε-caprolactone) 
Since the mannose binding efficiency to the lectin Con A is proposed to increase tremendously 
with its multivalency, a high molar mass linear polymer backbone was selected as a target. The 
glycodendrons were visualized to be attached to the polymer chain via an alkyne-azide 
cycloaddition “click” reaction owing to the high coupling efficiency of the reaction. In order for 
the dendronized polymer to have a sufficiently large number of functional groups, the polymer 
molar mass of 10,000 g/mol or more with more than 50 functionalizable pendant azide groups 
per chain was targeted. To compare the effect of the length of polymer chain on binding affinity, 
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a polymer with smaller number of repeat units was also used to synthesize a dendronized 
polymer.  
Synthesis of the required monomer followed the previously reported strategy
80
. A commercially 
obtained α-chlorohexanone was dissolved in DCM and stirred with meta-chloroperoxybenzoic 
acid (mCPBA) for 96 hours. The residual mCPBA and reaction byproducts were precipitated by 
cooling the reaction mixture to -20 C and filtered. The filtrate was further purified by washing it 
with sodium metasulphite and sodium carbonate solutions to yield the monomer following 
evaporation of the solvent. The monomer was freshly synthesized, stored for not more than 24 
hrs at low temperatures and freshly distilled before use.  
 
Scheme 2.10: Synthesis of α-chloro-ε-caprolactone monomer 
Ring-opening polymerization is the commonly used method to polymerize ε-caprolactone81, 82, 83. 
To avoid chain initiation as well as chain degradation by water, the polymerization was 
performed under dry conditions. Oven-dried glassware was used and the starting materials were 
added under a constant flow of argon in a Schlenk flask.  
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Scheme 2.11: Synthesis of α-azido-caprolactone polymer using methanesulfonic acid as catalyst 
PCL with pendant azide group has been previously prepared and reported as a homopolymer
84, 85
 
as well as copolymer
86, 87, 88
 with polycaprolactone using a variety of catalysts and initiators.  
In the initial polymerization attempts, ring-opening polymerization with methanesulfonic acid 
(MSA) as the catalyst and benzyl alcohol as the initiator were selected, as these reaction 
conditions have previously been successfully applied in our group to prepare PEO-PCL
89
. Acid 
catalyzed polymerization of ε-caprolactone proceeds by an activated monomer (AM) mechanism 
in a controlled/living manner
90
. The monomer was freshly distilled over calcium hydride and the 
initiator over molecular sieves prior to the polymerization. The reaction times were varied from 
2.5-48 hrs, and the temperature was varied from 30-60 C, but the desired length and 
polydispersity of the polymer could not be obtained, possibly because of the side reactions 
during the polymerization which led to more than one chain per molecule of the initiator, thereby 
decreasing the average molar mass and broadening the molar mass distribution. The number 
average molar masses (Mn) obtained by cationic ROP using MSA were consistently between 
1000-3000 g/mol, as measured by size exclusion chromatography (SEC) relative to polystyrene 
standards. The dialysis of polymer in DMF with a 6000-8000 MWCO membrane was useful in 
removing some of the oligomeric chains and narrowing down the polydispersity in some cases. 
Therefore, this method allowed for the preparation of a lower molar mass polymer chain (39D in 
table 2.1) which was deemed to be useful for evaluating the effect of chain length on lectin 
binding. However, a method was still needed for the preparation of the target higher molar mass 
backbone. 
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No. SEC Mn Polydispersity 
index (PDI) 
Temp (C) Reaction time (hrs) Notes 
39A 1950 1.2 30 2.5  
39B 2990 2.4 30 2.5  
39C 2120 2.2 30 2.5 Dialyzed 6000-
8000 g/mol 
MWCO 
39D 2380 1.3 30 2.5 Dialyzed 6000-
8000 g/mol 
MWCO 
39E 2490 1.2 60 3.5 Degraded (as 
per NMR) 
39F 8400 1.6 30 16 Dialyzed 6000-
8000 MWCO 
39G 2790 1.6 40 48 Degraded (as 
per NMR) 
Table 2.1: Summary of attempts at polymerization using MSA as catalyst 
At this stage, ring opening polymerization with tin(II) 2-ethylhexanoate [Sn(Oct)2] as the catalyst 
was investigated as it has been previously used to make α-substituted ε-caprolactone polymers 
via ring-opening polymerization
91
 and is a commonly used catalyst for the polymerization of ε-
caprolactone
88,84,92.
 The product was polymerized via ring opening polymerization with benzyl 
alcohol as the initiator in dry toluene, as shown in scheme 2.12. As shown in table 2.2, the 
reaction time was varied to determine the time dependence of the conversion and the influence of 
transesterification and back-biting degradation. Using benzyl alcohol as initiator and Sn(Oct)2 as 
catalyst and stirring the reaction mixture for 35 hrs at 120 C, a polymer with an Mn of 12400 
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and PDI of 1.5 was obtained (39L from table 2.2), which was deemed to be sufficient for further 
studies. 
 
Scheme 2.12: Synthesis of α-azido-caprolactone polymer using Sn(Oct)2 as catalyst 
No. SEC Mn PDI Temp (C) Reaction time (hrs) Notes 
39H 11930 1.5 120 16 Dialyzed 25,000 
g/mol MWCO 
39I 5100 1.8 120 48 Degraded (as per 
NMR) 
39J 3960 1.9 120 24  
39K 9030 1.4 120 35 Dialyzed 25,000 
g/mol MWCO 
39L 12430 1.5 120 35  
 
Table 2.2: Summary of attempts at polymerization using Sn(Oct)2 as catalyst 
As shown in scheme 2.12, a nucleophilic substitution reaction was then performed to convert the 
α-chloro group of the polymer to an α-azido group by stirring the polymer with sodium azide in 
DMF. The salts were removed from the reaction by centrifugation in toluene to yield the azide 
functionalized polymer. In order to remove the shorter oligomeric units and narrow the molar 
mass dispersity of the polymer, DMF dialysis was performed using a 25,000 g/mol MWCO 
membrane. Since the solubility of the polymer in water was very low, DMF was chosen as a 
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solvent. It should be noted that the cellulose pores of the dialysis membrane have a tendency to 
shrink about 3 to 4-fold in DMF and hence at MWCO of 25,000 g/mol would only remove 
impurities below 6000-8000 g/mol. Dialysis, nevertheless, proved very helpful in decreasing the 
molecular weight distribution of the polymer to 1.5. 
 
Figure 2.6: Comparison of IR spectra of polymers 38 and 39 
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Figure 2.7: SEC traces of polymer 39 before and after dialysis 
2.2.1.2 Conjugation of glycodendrons to poly(α-chloro-ε-caprolactone) 
In the current work, the ‘graft-to’ approach for synthesizing the dendronized polymer was 
selected. In order to achieve the highest degree of multivalency, the molar mass of the polymer 
chain was envisioned to be about 10 kg/mol. Based on the target polymer length, as well as our 
group’s well-established procedures35 for the divergent synthesis of dendrons with alkyne focal 
point moieties, this was anticipated to be the most efficient approach. In addition, the 
independent synthesis of the dendrons ensures that they are well-characterized and defect-free.  
The copper-catalyzed alkyne-azide cycloaddition “click” reaction of azides and terminal alkynes 
has been established to be a highly efficient reaction for the modification of polymers
93
. This 
particular reaction is highly selective and generally produces very a high yield in either organic 
or aqueous media, requiring only mild experimental conditions, and hence was selected for an 
efficient conjugation of glycodendrons to the polymer backbone.  
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In order to optimize the reaction conditions for conjugation of glycodendrons to the polymer 
backbone, a model reaction was run using polymer 39D (from table 2.1 above). This polymer 
was composed of ~15 azide-functionalized caprolactone and the target was to couple it with the 
hydroxyl terminated dendron 7 of generation 2. Dendron 7 was chosen because it was available 
on large scale for trial reactions. It was envisioned that the shifting of the relevant peaks in the 
1
H NMR spectrum could be a fairly reliable estimate of the reaction completion. It was also 
anticipated that IR spectroscopy would provide semi-quantitative information due to the strong 
azide stretch at 2108 cm
-1
 which should disappear upon its reaction with the alkyne. 
Following a previously established procedure for such copper-catalyzed alkyne-azide 
cycloaddition “click” coupling reactions94,72, 1.1 equivalents of dendron, 2.2 equivalents of 
copper sulfate and 4.4 equivalents of sodium ascorbate were used per azide group. Careful 
choice of the solvent system was required taking into account the difference of solubility of the 
dendron and the polymer in water, the dendron showing significantly more hydrophilicity in 
aqueous systems compared to the polymer which was essentially hydrophobic. In addition to 
that, the poor solubility and hence decreased activity of the catalysts in organic solvents 
necessitated a mixture of water and organic solvent as an ideal solvent system to the reaction. In 
this regard, a mixture of DMF and water (9:1 ratio) was chosen and the reaction mixture was 
stirred at 40 °C for 48 hours.  
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Scheme 2.13: Conjugation of dendron 7 with polymer 39 
A 
1
H NMR spectrum obtained after removal of residual copper and other reagents such as excess 
dendron by ethylenediaminetetraacetic acid disodium salt (Na2EDTA) dialysis at pH=7, followed 
by pure water dialysis, showed clear conversion of azide units to 1,2,3-triazole units with the 
attachment of dendrons through shifting of the alkyne focal point peak from 2.96 to a triazole 
proton peak at 8.22 (figure 2.8) and in addition, IR spectroscopy showed complete disappearance 
of the azide peak of the polymer after conjugation with the dendron. 
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Figure 2.8: 
1
H NMR spectrum of a) 7 (in CD3OD), b) 39 (in CDCl3), c) 40 (in CD3SOCD3) at 
400MHz frequency 
Hence, this reaction system was chosen for the conjugation of mannose-terminated dendrons 26 
and 27 to the polycaprolactone backbone and this procedure was then used to prepare the target 
dendronized polymers of generation 2 and 3 using two polymers 39D and 39L from tables 2.1 
and 2.2 above. To compare the effect of the absence of dendritic architecture on the dendronized 
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polymers, alkyne functionalized mannose 31 was also coupled to the polymers. 1.1 equivalents 
of the glycodendron (or 31) to 1 equivalent of azide on the polymer were added to a solution in 
DMF:water (9:1) and the reaction mixture was stirred at 40 C for 48 hrs in all the three 
reactions. EDTA is a very good copper-binding ligand and the resulting complex is easily 
purifyable using dialysis. The resulting products were purified by dialysis against a 25,000 g/mol 
(6000-8000 g/mol for 31) MWCO membrane in water with EDTA to remove the residual copper 
from the solution, followed by dialysis in pure water to remove the EDTA.  
The resulting products were characterized via infrared spectroscopy with further characterization 
by 
1
H NMR spectroscopy and SEC to be undertaken as part of future work. The IR spectrum of 
the generation 3 dendronized polymer 43 clearly showed the reduction in the azide peak 
intensity, indicating the dendron functionalization to the polymer to a good extent. 
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Scheme 2.14: Synthesis of dendronized polymers (D=from polymer 39D; L=from polymer 39L) 
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Figure 2.9: IR spectra of a) 39, b) 27 and c) 43L for comparison 
2.2.2 Linear-Dendron Hybrids 
Linear-dendron hybrids are block copolymers with a dendritic unit coupled to a linear polymer. 
If the copolymer is amphiphilic, containing hydrophobic and hydrophilic segments, it can self-
assemble into various nano-sized structures. A polypeptide PBLG conjugated with the 
glycodendrons 33, 34 and 35 displaying α-galactose units on the periphery was chosen to study 
their self-assembly behavior as well as the protein binding properties of the conjugated α-
galactose. 
Residual azide peak  
63 
 
 
Scheme 2.15: Synthesis of linear dendron hybrid (Reproduced from a presentation by Justine Ades, 
University of Bordeaux) 
In this collaborative work, done with the Lecommandoux group in the University of Bordeaux, 
France, the dendritic entities with α-galactose on the periphery were prepared by our lab with the 
aim of coupling them to PBLG prepared in the Lecommandoux group. PBLG is useful in such 
studies, being a synthetic biomimetic polymer. It has been shown that the helical conformation of 
a hydrophobic PBLG is an efficient way to form and stabilize vesicles
95
. Block copolymers 
consisting of PBLG and conjugated with β-galactose on the surface have been used to form 
biomimetic polymersomes
96
. It is anticipated that the competing effects of dendron architecture 
favoring the formation of micellar assemblies and peptide rigidity favoring lamellar/vesicular 
morphologies will lead to interesting fundamental insights into polymer assembly with potential 
applications arising from the carbohydrate moieties. 
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2.2.2.1 Synthesis of Linear-Dendron Hybrids 
Studies have been conducted in our collaborator’s laboratory towards the synthesis and self-
assembly of the proposed linear-dendron hybrids. Linear PBLG with a terminal azide group and 
varying degrees of polymerization (table 2.3) were synthesized by the ring opening 
polymerization of ɣ-benzyl-L-glutamate N-carboxyanhydride monomer with a 1-azido-3-
aminopropane initiator
97
. Hydroxyl-terminated dendron 8 was used as a model dendron and was 
conjugated with azide-terminated PBLG under copper-catalyzed alkyne-azide cycloaddition 
“click” reaction conditions (scheme 2.15) in dimethyl sulfoxide (DMSO) using copper sulphate 
and sodium ascorbate as reagents. The success of this reaction was confirmed by SEC, NMR, 
and IR spectroscopy, so these conditions were subsequently applied to galactose dendrons of 
generation 2, 3 and 4 (33, 34 and 35 respectively) to prepare a small library of synthetic 
glycopolypeptides (table 2.3).  
 
 
 
 
 
Table 2.3: Molecular characteristics of α-functionalized building blocks for click-chemistry 
2.2.2.2 Self-Assembly of Linear-Dendron Hybrids 
The self-assembly behavior of these linear-dendritic glycopolypeptides as well as the model 
compound prepared from the hydroxyl terminated dendron 8 was studied by using the 
Glycodendron Structure MW 
G2 G2-galactose 33 1680 
G3 G3-galactose 34 3430 
G4 G4-galactose 35 6920 
G3b G3-OH 8 870 
Polymer DP MW 
P14 14 3170 
P28 28 6230 
P54 54 11920 
DP: Degree of Polymerization 
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nanoprecipitation method. This involved either the rapid injection of a DMSO solution of the 
polymer into pure water, or the use of a syringe pump for the controlled addition of water into 
the DMSO solution of polymer (figure 2.10) 
 
 
Figure 2.10: Nanoprecipitation method for self-assembly of linear-dendron hybrids 
On injecting the solution of glycopolypeptide P28-G4 in DMSO into water, aggregates of 
hydrodynamic diameter of 24 nm with a relatively low polydispersity (PDI=0.25) were obtained. 
Transmission electron microscopy (TEM) images (figure 2.11) were consistent with the dynamic 
light scattering (DLS) results and showed micellar morphologies. 
 
Figure 2.11: TEM images. Fast addition of DMSO into water of (A) P28-G4, unstained 
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Turbid solutions of macroscopic aggregates were obtained with the rapid injection of DMSO into 
water for P14-G2, P28-G2, P28-G3 and P54-G3. Thus, only the fourth generation galactose-
functionalized dendron was sufficient to stabilize assemblies in water. It is suggested that the 
carbohydrates are strongly hydrated in solution and as a result, they induce a curvature that 
disfavors lamellar packing that would otherwise be favored based on the hydrophilic mass ratio.  
Interestingly, P54-G3b exhibiting the lowest hydrophilic weight fractions of 0.07 was able to 
assemble as nano-objects in solution, probably because it is less densely packed and can 
therefore assemble more easily. An increase in size was observed with the decrease of the flow 
rate when injecting water into the DMSO solution of the glycopolypeptides (while keeping a 
relatively low dispersity). TEM confirmed the sizes obtained by DLS. As shown in figure 2.12 
(a), (b) and (c), P54-G3b self-assemble as spherical objects with increasing sizes depending on 
the flow rate. 
 
 Fast  64 mL/hr  8 mL/hr  
Sample DH (nm) PDI DH (nm) PDI DH (nm) PDI 
P54-G3b 40 0.14 84 0.17 175 0.18       
 
Table 2.4: DLS measurement data of self-assembly of P54-G3b  
(DH = hydrodynamic diameter), (PDI= Polydispersity index)        
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Figure 2.12: TEM images, addition of water into the DMSO solution of P54-G3b: (a) fast addition, 
uranyl stained, (b) 64 mL/hr, and (c) 8 mL/hr. 
2.2.2.3 Lectin binding studies 
Lectin binding studies are currently underway. Preliminary results suggest that the nanoparticles 
formed by the assembly of P28-G4 can precipitate isolectin B4 from Griffonia simplicifolia at a 
concentration where dendron G4 or control particles formed from P54G3b do not. Griffonia 
simplicifolia (BS1-B4) is a tetrameric legum lectin that specifically binds α-galactose residues 
(contrary to most lectins that lack anomeric specificity). This suggests a benefit in terms of 
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binding affinity arising from the high multivalency of these nanoparticles. However, in a 
hemagglutination assay it was found that all of these assemblies actually agglutinate red blood 
cells. The reason for this effect is not clear at this time, but it prevents the use of this valuable 
assay, which would otherwise enable the measurement of relative binding affinities. 
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Chapter 3 
3 Conclusions and Future Work 
3.1 Conclusions 
In conclusion, amine functionalized dendrons of generations 1, 2, 3 and 4 were synthesized via 
DCC and EDC coupling reactions of hydroxyl groups to the carboxylic acid groups on Boc-
protected-β alanine. All but the generation 3 system were new molecules and were characterized 
using 
1
H NMR, 
13
C NMR, IR spectroscopy and MALDI spectrometry. They are expected to 
serve as useful scaffolds for further chemistry both in this thesis and in the broader area of 
dendrimer bioconjugates. Isothiocyanate functionalized mannose was synthesized via a 
glycosylation reaction on a mixture of fully protected α and β anomers of mannose to yield 
(2,3,4,6-tetraacetyl-(2-azidoethyl))-α-D-mannopyranoside, which was then used to synthesize (2-
isothioethyl)-α-D-mannopyranoside by an improved procedure. The dendrons of generation 1-4 
were then coupled to the isothiocyanate functionalized carbohydrate to yield the respective 
glycodendrons. The glycodendrons of generation 2 and 3 were fully characterized by 
1
H NMR, 
13
C NMR and IR spectroscopy.  
For the preparation of glyco-dendronized polymers, azide functionalized caprolactone 
homopolymers of two different degrees of polymerizations were synthesized using benzyl 
alcohol as initiator and MSA and Sn(Oct)2 as catalysts respectively. The Sn(Oct)2 catalyst was 
found to afford better results in terms of degree of polymerization. An alkyne-functionalized 
mannose was synthesized to couple the sugar to the polymer backbone to study the effect of 
dendritic structure on binding affinities of dendronized polymer. This mannose derivative, as 
well as the glycodendrons of generation 2 and 3, were conjugated to the polymers via copper-
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catalyzed alkyne-azide alkyne-azide cycloaddition “click” reaction to yield a small library of 
dendronized polymers. IR spectroscopy revealed a significant extent of dendron conjugation to 
the polymer. 
These amine functionalized dendrons were also coupled to a C-linked isothiocyanate derivative 
of galactose synthesized by Dr. John Trant in the Gillies group and galactose terminated 
glycodendrons of generation 2 to 4 were isolated and characterized. These glycodendrons as well 
as hydroxyl terminated dendron of generation 3 were further coupled with polypeptides PBLG of 
different degrees of polymerization in the Lecommandoux group in the University of Bordeaux, 
France to generate a small library of linear dendron hybrids. Self-assembly behavior of these 
hybrids was studied in the Lecommandoux group and aggregates of hydrodynamic diameter of 
24 nm with a relatively low polydispersity (PDI=0.25) were obtained for generation 4 dendron 
coupled with PBLG with 28 repeat units. Hybrids of PBLG 54 and hydroxyl terminated 
generation 3 dendron self-assemble as spherical objects with increasing sizes depending on the 
flow rate. These aggregates were studied using light scattering and the size profile was consistent 
with the values measured via TEM.  
3.2 Future Work 
The future work will involve the further characterization of dendronized polymers with 
1
H NMR, 
13
C NMR and SEC in aqueous media as well as calculation of their conjugation yields. In 
addition, complete characterization of generation 4 mannose glycodendron will be done 
following which its corresponding dendronized polymers will be synthesized with different 
degrees of polymerization of the polymer backbone. 
71 
 
Lectin-binding properties of these materials will be evaluated using a variety of biological assays 
including the hemagglutination assay for mannose-terminal dendronized polymers, and 
compared to the binding properties of the non-scaffolded saccharide molecules.  
In addition, the hydrophilicity of the linear dendron hybrids will be tuned by the preparation of 
triblock systems incorporating PBLG, poly(ethylene oxide) and the dendron, with the aim of 
preventing the aggregation problems that were observed for many of the linear-dendron hybrids. 
Further lectin binding and biological studies of the new self-assembled aggregates will follow. 
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Chapter 4 
4 Experimental  
4.1 General procedures and materials 
Dendrons 5, 7, 8 and 9 were prepared as previously reported in the literature
61
. All the reagents 
were purchased from commercial suppliers and used without further purification unless 
otherwise noted. Anhydrous DMF and toluene was obtained from a solvent purification system. 
Triethylamine (Et3N), N,N-Diisopropylethylamine (DIPEA) and dichloromethane (CH2Cl2) were 
distilled from calcium hydride (CaH2). Moisture-sensitive reactions were performed under an 
argon atmosphere using flame or oven-dried glassware. Column chromatography was performed 
using silica gel (0.063-0.200 mm particle size, 70-230 mesh). 
1
H NMR spectra were obtained at 
400 MHz or 600 MHz and 
13
C NMR spectra were obtained at 100 or 150 MHz using a Varian 
Mercury or Varian Inova spectrometer. NMR chemical shifts are reported in ppm and are 
calibrated against residual solvent signal of CDCl3 (δ7.27, 77.2), CD3OD (δ3.31, 49.15) or 
CD3SOCD3 (δ2.50, 39.52). Infrared spectra were obtained either as films from methanol/THF, 
DCM or methanol on sodium chloride (NaCl) plates, or via attenuated total reflection by direct 
placement of the solid-state sample on a KBr crystal. Dialysis of the dendrons was performed 
using Spectra/Por regenerated cellulose membranes with various MWCO. Freeze-drying was 
carried out using a Labconco FreeZone 2.5 plus lyophilizer. SEC was performed in DMF using a 
Waters 2695 separations module equipped with a 2414 differential refractometer and two PLgel 
5 μm mixed-D (300 mm × 7.5 mm) columns from Polymer Laboratories. Polymer MWs were 
calculated using the Wyatt Astra software, with dn/dc values of the polymers determined from 
the refractive index (RI) detector using Astra. MALDI-TOF (time of flight) mass spectrometry 
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data were obtained using a 4700 Proteomics Analyzer, MALDI TOF (Applied Biosystems, 
Foster City, CA, USA). 2-(4'-hydroxybenzeneazo)benzoic acid (HABA) was used as the matrix 
for the measurements. Reflectron and linear positive ion modes were used. All monomers, 
initiators and catalysts were dried by azeotropic distillation (×3) with dry toluene using a Schlenk 
line system under argon. Centrifuge VMR clinical 200 
4.2 Experimental Section 
Synthesis of dendron 11: Dendron 5 (2.0 g, 11.56 mmol, 1 equiv.) and boc-protected β-alanine 
(8.75 g, 46.24 mmol, 4 equiv.), were dissolved in distilled pyridine (4.6 mL, 5 equiv.). EDC.HCl 
(7.18 g, 46.24 mmol, 4 equiv.) and DMAP (5.64 g, 69.36 mmol, 4 equiv.) were added  to the 
mixture. 40 mL of anhydrous CH2Cl2 was added to dissolve all the reagents and starting 
materials. The mixture was stirred at room temperature for 36 hours. The solution was then 
diluted with 100mL of CH2Cl2, and washed with H2O (1x 50 mL), 1M HCl (3x 50 mL), 1M 
Na2CO3 (2x 50 mL), and brine (1x 50 mL). The organic phase was isolated and dried with 
MgSO4, filtered and solvent removed in-vacuo. It was further purified by column 
chromatography (2:1 hexanes/ethyl acetate) to give 4.9 g (82%) of 11. 
1
H NMR (CDCl3): δ 5.19 
(br s, 2H), 4.75 (d, 2H, J=2.6 Hz), 4.31- 4.21 (m, 4H), 3.37 (m, 4H), 2.53 (t, 4H, J=6.2 Hz), 1.42 
(s, 18H), 1.27 (s, 3H). 
13
C NMR (CDCl3): δ: 171.76, 155.62, 79.16, 76.92, 75.32, 64.89, 53.31, 
52.52, 46.24, 35.91, 34.32, 28.19, 17.50. MALDI-TOF molar mass: 537.2. Calculated [M+Na
+
]: 
537.5 
Synthesis of dendron 13: Dendron 7 (4.25 g, 10.52 mmol, 1 equiv.) and boc-protected β-alanine 
(15.90 g, 84.16 mmol, 8 equiv.), were dissolved in distilled pyridine (8.4 mL, 10 equiv.). 
EDC.HCl (13.06 g, 84.16 mmol, 8 equiv.) and DMAP (10.27 g, 84.16 mmol, 8 equiv.) were 
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added. 50 mL of anhydrous CH2Cl2 was added to dissolve all the reagents and starting materials. 
The mixture was stirred at room temperature for 36 hours. The solution was then diluted with 
100mL of CH2Cl2, and washed with H2O (1x 50 mL), 1M HCl (3x 50 mL), 1M Na2CO3 (2x 50 
mL), and brine (1x 50 mL). The organic phase was isolated and dried with MgSO4, filtered and 
solvent removed in-vacuo. It was further purified by column chromatography (1.5:1 
hexanes/ethyl acetate) to give 9.1 g (80%) of 13. 
1
H NMR(CDCl3): δ  5.18 (br, 1H), 4.74 (d, 2H, 
J=2.3 Hz), 4.31-4.10 (m, 12H), 3.33 (d, 8H, J=5.8 Hz), 2.52-2.48 (t, 8H, J=6.6 Hz), 1.38 (s, 
36H), 1.24 (s, 3H). 
13
C NMR (CDCl3): δ: 171.85, 171.30, 155.66, 79.17, 76.90, 75.63, 65.49, 
64.78, 60.21, 52.75, 46.52, 46.34, 35.96, 34.29, 33.80, 28.24, 20.87, 17.68, 17.35. MALDI-TOF 
molar mass: 1111.5. Calculated [M+Na
+
]: 1111.2 
Synthesis of dendron 15: Dendron 8 (0.16 g, 0.19 mmol, 1 equiv.) and boc-protected β-alanine 
(0.56 g, 2.96 mmol, 16 equiv.), were dissolved in distilled pyridine (0.3 mL, 20 equiv.). 
EDC.HCl (0.46 g, 2.96 mmol, 16 equiv.) and DMAP (0.36 g, 2.96 mmol, 16 equiv.) were added. 
10 mL of anhydrous CH2Cl2 was added to dissolve all the reagents and starting materials. The 
mixture was stirred at room temperature for 36 hours. The solution was then diluted with 15mL 
of CH2Cl2, and washed with H2O (1x 15 mL), 1M HCl (3x 15 mL), 1M Na2CO3 (2x 15 mL), and 
brine (1x 15 mL). The organic phase was isolated and dried with MgSO4, filtered and solvent 
removed in-vacuo. It was further purified by column chromatography (1:1 hexanes/ethyl acetate) 
to give 0.36 g (85%) of 15. Spectral data were in accordance with literature values
35
.   
Synthesis of dendron 17: Dendron 9 (0.5 g, 0.25 mmol, 1 equiv.) and boc-protected β-alanine 
(1.50 g, 8.18 mmol, 32 equiv.), were dissolved in distilled pyridine (8.4 mL, 40 equiv.). 
EDC.HCl (1.27 g, 8.18mmol, 32 equiv.) and DMAP (1.0 g, 8.18 mmol, 32 equiv.) were added. 
20 mL of anhydrous CH2Cl2 was added to dissolve all the reagents and starting materials. The 
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mixture was stirred at room temperature for 36 hours. The solution was then diluted with 20 mL 
of CH2Cl2, and washed with H2O (1x 20 mL), 1M HCl (3x 20 mL), 1M Na2CO3 (2x 20 mL), and 
brine (1x 20 mL). The organic phase was isolated and dried with MgSO4, filtered and solvent 
removed in-vacuo. It was further purified by column chromatography (1:1 hexanes/ethyl acetate 
to remove by products and starting materials, pure ethyl acetate to extract product) to give 0.87 g 
(76%) of x. 
1
H NMR (CDCl3): δ 5.27 (br, 1H), 4.73 (d, 2H, J=2.3 Hz), 4.27-4.16 (m, 60H), 3.36 
(d, 32H, J=5.8 Hz), 2.53 (t, 32H, J=6.6 Hz), 1.42 (s, 144H), 1.33 (s, 3H), 1.27 (s, 6H), 1.26 (s, 
12H), 1.25 (s, 24H). 
13
C NMR: δ: 171.56, 171.37, 155.41, 79.26, 77. 21, 64.87, 53.51, 46.70, 
36.12, 34.42,28.38, 17.79, 17.50 
Synthesis of dendron 12: Dendron 11 (0.25g, 0.48mmol) was dissolved in 1mL of 1:1 
TFA/CH2Cl2 and the solution was stirred at room temperature for 1 hour. The solvent was 
removed in vacuo to provide 98  of product as light brownish viscous oil and stored at -4 C. 1H 
NMR (CD3OD): δ: 4.76 (d, 2H, J=2.3 Hz), 4.34 (m, 4H), 3.21 (t, 4H, J=6.7 Hz), 3.02 (t, 1H, 
J=2.5 Hz), 2.76 (t, 4H, J=6.6 Hz), 1.31 (s, 3H). 
13
C NMR (CDCl3): δ 173.47, 173.47, 171.82, 
78.46, 76.74, 67.05, 53.79, 47.77, 36.41, 32.18, 17.94. 171.82, 78.46, 76.74, 67.05, 53.79, 47.77, 
36.41, 32.18, 17.94. MALDI-TOF molar mass found: 337.1. Calculated [M+Na
+
]: 337.1 
Synthesis of dendron 14: Dendron 13 (0.25g, 0.23mmol) was dissolved in 1mL of 1:1 
TFA/CH2Cl2 and the solution was stirred at room temperature for 2 hours. The solvent was 
removed in vacuo to provide 98  of product as light brownish viscous oil and stored at -4 C. 1H 
NMR (CD3OD) δ: 4.79 (d, 2H, J=2.3 Hz), 4.35-4.26 (m, 12H), 3.22 (t, 8H, J=6.4 Hz), 3.02 (t, 
1H, J=2.3 Hz), 2.79 (t, 8H, J=7.0 Hz), 1.33 (s, 3H), 1.29 (s, 6H) 
13
C NMR (CD3OD): δ: 173.63, 
171.91, 78.59, 77.20, 67.06, 53.96, 47.83, 39.50, 36.40, 34.84, 32.24, 26.84, 26.18, 18.13. 
MALDI: MALDI-TOF molar mass found: 711.3. Calculated [M+Na
+
]: 711.3 
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Synthesis of dendron 16: Dendron 15 (0.1g, 0.04mmol) was dissolved in 1mL of 1:1 
TFA/CH2Cl2 and the solution was stirred at room temperature for 2.5 hours. The solvent was 
removed in vacuo to provide 98  of product as light brownish viscous oil and stored at -4 C. 
Spectral data agreed with those previously reported
35
. 
Synthesis of dendron 18: Dendron 17 (0.25g, 0.05 mmol) was dissolved in 1mL of 1:1 
TFA/CH2Cl2 and the solution was stirred at room temperature for 4 hours. The solvent was 
removed in vacuo to provide 94  of product as light brownish viscous oil and stored at -4 C. 1H 
NMR (CD3OD) δ: 4.80 (d, 2H, J=2.3 Hz), 4.35-4.28 (m, 60H), 3.25 (t, 32H, J=6.4 Hz), 2.85 (t, 
1H, J=2.3 Hz), 2.82 (t, 32H, J=7.0 Hz), 1.37 (s, 3H), 1.34 (s, 6H), 1.31 (s, 12H), 1.29 (s, 24H). 
MALDI: Found (MALDI-TOF): 2955.8. Calculated [M+S<->O+K
+
]: 2956.1 
Synthesis of azidoethanol: 2-bromoethanol (25 g, 200 mmol, 1.0 equiv.) and sodium azide (18.2 
g, 280 mmol, 1.4 equiv.) were refluxed at 100 °C for 48 hours in a solvent-free reaction. The 
reaction mixture was then diluted with diethyl ether and filtered under vacuum to remove sodium 
azide. Diethylether was removed by evaporation. Any residual ethanol was removed by 
evaporation under vacuum to yield the product as light yellow oil (14.9 g, 86 %), which was 
stored under molecular sieves until further use. Spectral data agreed with those previously 
reported
35
.  
Synthesis of 21 (2,3,4,6-tetraacetyl-(2-azidoethyl))-α-D-mannopyranoside: Under a nitrogen 
atmosphere, α, β-D-mannose pentaacetate, (3.7 g, 9.4 mmol, 1 equiv.) and azidoethanol (1.2 g, 
14 mmol, 1.5 equiv.) were dissolved in anhydrous CH2Cl2 (12 mL) and the solution  was cooled 
to 0˚C. BF3·OEt2 (5.8 mL, 47 mmol, 5 equiv.) was added dropwise and the resulting solution 
was stirred at 0˚C for one hr and then at room temperature for an additional 24 hrs. The solution 
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was monitored by 1H NMR for the disappearance of the peak at 6.10 ppm (anomeric peak for 
1,2,3,4,6-pentaacetyl-α-D-mannopyranoside). An additional 2.5 mL BF3·OEt2 was added to 
further catalyze the reaction. After 12 hours the reaction solution was diluted with 20 mL of 
chloroform, washed with H2O (3x 15 mL), and 1M aqueous NaHCO3 (3x 15 mL) to give 2.7 g of 
21 (69.5%). Spectral data agreed with those previously reported
35
.  
Synthesis of 22 (2-azidoethyl)-α-D-mannopyranoside: 21 (2.7 g, 6.6 mmol) was stirred with 6 
mL of NaOMe/MeOH solution in 10 mL of methanol (pH 7.6-8.0) at room temperature for two 
hours. The solution was then neutralized with Dowex (H+), filtered and concentrated under 
reduced pressure. The product, 22, was isolated as an oil (1.5 g, 91%). Spectral data agreed with 
those previously reported
35
. 
Synthesis of 23 (2-aminoethyl)-α-D-mannopyranoside: 22 (1.0 g, 4.0 mmol) was dissolved in 
25 mL of MeOH, flask was degassed thrice under vacuum to remove oxygen and argon was 
introduced into the flask. 150 mg of 10% Pd/C catalyst was added. The atmosphere was 
exchanged for H2 gas and the solution was stirred vigorously at room temperature. After 6 hours, 
the reaction was complete and the mixture was diluted with 1 mL of H2O( for amine solubility), 
filtered over celite and concentrated in vacuo to yield the product, 23 (0.80 g, 90%). Spectral 
data agreed with those previously reported
35
.  
Synthesis of 24 (2-isothioethyl)-α-D-mannopyranoside: 23 (50 mg, 0.22 mmol) was dissolved 
in 5 mL 80% EtOH in water and DIPEA (1.12 mmol, 195µl) was added. Thiophosgene (0.52 
mmol, 40µl) was added and the reaction was stirred at room temperature for 2 hours. The 
solution was maintained at basic pH throughout the reaction time. Ethanol was removed by 
rotavap and the remaining solution was freeze dried using liquid nitrogen and a lyophilizer 
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overnight to remove water. The product was used without further purification. Spectral data 
agreed with those previously reported
35
.  
Synthesis of glycodendron 26: 14 (0.96 g, 0.84 mmol, 1 equiv.) was dissolved in dry DMF (10 
mL) and DIPEA (6 mL) was added. 24 (2.36 g, 8.4 mmol, 10 equiv.) was added as a solution in 
dry DMF (20 mL). The reaction mixture was stirred under argon at room temperature for 64 
hours. The solvent was removed in vacuo and the crude product was dissolved in fresh DMF (5 
mL) and dialyzed in DMF (500 mL) using a 1000 MWCO membrane for 48 hours and in pure 
water for 6 hours. The water was removed by freeze drying and product (300 mg, 20.6%) was 
isolated as a hygroscopic, brown powder. 
1
H NMR (CD3SOCD3) δ: 4.98 (br, 2H), 4.73 (br, 2H), 
4.71 (br, 4H), 4.62 (br, 4H), 4.55 (d, 3H, J=4.7 Hz), 4.44 (t, 4H, J=5.8 Hz), 4.11-4.24 (m, 15H), 
3.66-3.56 (m,17H), 3.51 (br,4H), 3.49-3.43 (m, 10H), 3.41-3.37 (m,4H), 2.61 (t,9H, J=5.2 Hz), 
1.17 (s,6H), 1.14 (s,3H). 
13
C NMR (CD3SOCD3) δ:179.18, 178.57, 107.42, 85.37, 81.41, 78.37, 
77.68, 74.39, 72.56, 68.64 53.51,50.51, 50.61, 43.23, 40.77, 24.64, 24.41, 18.13. 
Synthesis of glycodendron 27 16 (0.95 g, 0.40 mmol, 1 equiv.) was dissolved in dry DMF (10 
mL) and DIPEA (6 mL) was added. 24 (2.35 g, 8.8 mmol, 22 equiv.) was added as a solution in 
dry DMF (20 mL). The reaction mixture was stirred under argon at room temperature for 64 
hours. The solvent was removed in vacuo and the crude product was dissolved in fresh DMF (5 
mL) and dialyzed in DMF (500 mL) using a 1000 MWCO membrane for 48 hours and in pure 
water for 6 hours. The water by removed by freeze drying and product (350 mg, 24.5%) was 
isolated as a hygroscopic, brown powder. Spectral data was found to be in accordance with the 
literature value
35
.   
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Synthesis of glycodendron 28: 18 (0.95 g, 0.40 mmol, 1 equiv.) was dissolved in dry DMF (10 
mL) and DIPEA (6 mL) was added. 24 (2.35 g, 8.8 mmol, 22 equiv.) was added as a solution in 
dry DMF (20 mL). The reaction mixture was stirred under argon at room temperature for 64 
hours. The solvent was removed in vacuo and the crude product was dissolved in fresh DMF (5 
mL) and dialyzed in DMF (500 mL) using a 1000 MWCO membrane for 48 hours and in pure 
water for 6 hours. The water by removed by freeze drying and product (350 mg, 24.5%) was 
isolated as a hygroscopic, brown powder. Further characterization to follow in future work. 
Synthesis of alkyne functionalized mannose 30: Under a nitrogen atmosphere, α, β-D-mannose 
pentaacetate, (5 g, 12.88 mmol, 1 equiv.) and propargyl alcohol (1.08 g, 19.33 mmol, 1.5 equiv.) 
were dissolved in anhydrous CH2Cl2(30 mL) and the solution  was cooled to 0˚C. BF3·OEt2 (6.4 
mL, 64.4 mmol, 5 equiv.) was added dropwise and the resulting solution was stirred at 0˚C for 
one hour and then at room temperature for an additional 48 hours. The reaction solution was 
diluted with 50mL of chloroform, washed with H2O (3x 50 mL) and 1M aqueous NaHCO3 (3x 
50 mL) to give 3.6 g of 30 (73%). Spectral data agreed with those previously reported
76
. 
Synthesis of alkyne functionalized mannose 31: 30 (5.7g, 14.76 mmol) was stirred with 4 mL 
of NaOMe/MeOH solution in 40 mL of methanol (pH 7.6-8.0) at room temperature for 3 hours. 
The solution was then neutralized with Dowex (H+), filtered and concentrated under reduced 
pressure. The product, 31, was isolated as solid crystals (3.06 g, 94%). Spectral data agreed with 
those previously reported
76
. 
Synthesis of α-chloro-ε-caprolactone 37: Commercially obtained chlorocyclohexanone (10 gm, 
75 mmol, 1 equiv.) was dissolved in dry DCM (150 mL). mCPBA (70%, 24 gm, 98 mmol, 1.3 
equiv.) was added to the reaction flask. The reaction was run at room temperature for 96 hours 
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and monitored using NMR spectroscopy for the disappearance of starting material peaks. The 
solution was then cooled to -20  C and to precipitate residual mCPB , which was filtered off. 
The product diluted with 150 mL of CH2Cl2 was then washed with saturated Na2S2O5 (3x 100 
mL), 1M Na2CO3 (3x 100 mL) and brine (1x 100 mL). The organic phase was isolated and dried 
with MgSO4, filtered and solvent removed in-vacuo, and was used the same day. The spectral 
data was found to be in accordance with the literature values
81
. 
Synthesis of poly(α-azido-ε-caprolactone) 39D: The monomer 37 freshly distilled over CaH2 
(6.18 g, 41.75 mmol, 90 equiv.) and initiator benzyl alcohol freshly distilled on molecular sieves 
(50 mg, 0.4 mmol, 1 equiv.) were added to a flame dried Schlenk flask under argon through a 
Schlenk line with 1 mL of dry toluene. The reaction mixture was e uilibriated at 30  C for 10 
min. The catalyst methanesulfonic acid (44 mg, 0.4 mmol, 1 equiv.) was added and the reaction 
mixture was stirred at 30  C for 2.5 hours. The polymer was then dissolved in chloroform and 
precipitated in cold hexanes to give 38 as a light yellow oil. This polymer 38 was then dissolved 
in DMF (2 ml) and sodium azide (3.5 g, 53.84 mmol, 1.2 equiv.) was added. The reaction 
mixture was stirred at room temperature for 24 hours. The solvent was removed by distillation 
under vacuum and the crude polymer was dissolved in toluene (10 mL) and centrifuged for 15 
min at 6000 rpm thrice, each time with addition of fresh toluene. The toluene portions were 
collected and the solvent was removed in-vacuo to yield the crude product. This product was 
dissolved in 2 mL DMF and dialyzed in 200 mL DMF for 48 hours using a 6000-8000 g/mol 
MWCO. The solvent was removed in vacuo to yield polymer 39D. Spectral data agreed with 
those previously reported
81
. 
Synthesis of poly(α-azido-ε-caprolactone) 39L: The monomer 37 (1.8 gm, 12.16 mmol, 90 
equiv.), initiator benzyl alcohol (14 mg, 0.1 mmol, 1 equiv.) and catalyst Sn(Oct)2 (as a 10 
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mg/ml solution in dry toluene) (0.14 mg, 0.00033 mmol, 1/400 equiv.) were added to a flame 
dried Schlenk flask under argon through a Schlenk line and azeotropically dried under vacuum 
thrice by addition and evaporation of toluene (1 ml) in the flask. The reaction temperature was 
increased to 110 C and the reaction mixture was stirred for 96 hours under dry conditions. The 
polymer was then cooled to room temperature, dissolved in chloroform and precipitated in cold 
hexanes to yield polymer 38 a brown paste. This polymer was dissolved in DMF (7 mL) and 
sodium azide (0.7 g, 11.35 mmol, 1.2 equiv.) was added. The reaction mixture was stirred at 
room temperature for 24 hours. The solvent was removed by distillation under vacuum and the 
crude polymer was dissolved in toluene (10 mL) and centrifuged for 15 min at 6000 rpm thrice, 
each time with addition of fresh toluene. The toluene portions were collected and the solvent was 
removed in-vacuo to yield the crude product. This product was dissolved in 2 mL DMF and 
dialyzed in 200 mL DMF for 48 hrs using a 25000 g/mol MWCO. The solvent was removed in 
vacuo to yield polymer 39L. Spectral data agreed with those previously reported
81
. 
Synthesis of denpol 40: 39D (53 mg, 0.02 mmol, 1 equiv.) and 7 (150 mg, 0.37 mmol, 16.5 
equiv.) were each dissolved in DMF (2 mL) and added to a flask. Sodium ascorbate (0.3 g, 1.5 
mmol, 66 equiv.) was added as a solid powder. Copper sulfate (118 mg, 0.74 mmol, 33 equiv.) 
was added to the mixture as a solution in water (0.4 mL). Reaction mixture was stirred at 40  C 
for 48 hours. Additional sodium ascorbate (66 equiv.) was added to the mixture after the first 24 
hours. The reaction mixture was then dialyzed first against EDTA solution (5g/L, pH=7, 25000 
g/mol MWCO) for 12 hours with EDTA solution changed after the first 5 hours, and then against 
pure water overnight. The resulting aqueous mixture was lyophilized to yield the product 40. 
1
H 
NMR (CD3SOCD3) δ: 8.22 (br, 1H), 5.48 (br, 1H), 5.19 (br, 2H), 4.63 (br, 2H), 4.12 (br, 8H), 
3.44 (br, 6H), 2.15 (br, 2H), 1.54 (br, 3H), 1.17 (s, 3H) 0.98 (s, 6H) 
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Synthesis of denpol 41L: 39L (40 mg, 0.0031 mmol, 1 equiv.) and 7 (63 mg, 0.29 mmol, 93.5 
equiv.) were each dissolved in DMF (2 mL) and added to a flask. Sodium ascorbate (231 mg, 
1.17 mmol, 374 equiv.) was added as a solid powder. Copper sulfate (93 mg, 0.58 mmol, 187 
equiv.) was added to the mixture as a solution in water (0.4 mL). Reaction mixture was stirred at 
40  C for 48 hours. Additional sodium ascorbate (374 equiv.) was added to the mixture after the 
first 24 hours. The reaction mixture was then dialyzed first against EDTA solution (5g/L pH=7, 
6000-8000 g/mol MWCO) for 12 hours with EDTA solution changed after the first 5 hours, and 
then against pure water overnight. The resulting aqueous mixture was lyophilized to yield the 
product 41L. 
1
H NMR (D2O) δ: 8.14 (br, 1H), 5.39 (br, 1H), 4.88 (br, 2H), 4.08 (br, 2H), 3.93 
(br, 5H), 3.70 (br, 3H), 2.16 (s, 2H), 1.54 (br, 2H), 1.10 (br, 2H). Further characterization to 
follow in future work. 
Synthesis of denpol 42L: 39L (10 mg, 0.0012 mmol, 1 equiv.) and 7 (126 mg, 0.10 mmol, 93.5 
equiv.) were each dissolved in DMF (2 mL) and added to a flask. Sodium ascorbate (57 mg, 0.42 
mmol, 374 equiv.) was added as a solid powder. Copper sulfate (23 mg, 0.21 mmol, 187 equiv.) 
was added to the mixture as a solution in water (0.4 mL). Reaction mixture was stirred at 40  C 
for 48 hours. Additional sodium ascorbate (374 equiv.) was added to the mixture after the first 24 
hours. The reaction mixture was then dialyzed first against EDTA solution (5g/L pH=7, 25000 
g/mol MWCO) for 12 hours with EDTA solution changed after the first 5 hours, and then against 
pure water overnight. The resulting aqueous mixture was lyophilized to yield the product 42L. 
Further characterization to follow in future work.
 
 
Synthesis of denpol 43L: 39L (8.7 mg, 0.0066 mmol, 1 equiv.) and 7 (223 mg, 0.06 mmol, 93.5 
equiv.) were each dissolved in DMF (2 mL) and added to a flask. Sodium ascorbate (50 mg, 0.25 
mmol, 374 equiv.) was added as a solid powder. Copper sulfate (20 mg, 0.12 mmol, 187 equiv.) 
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was added to the mixture as a solution in water (0.4 mL). Reaction mixture was stirred at 40  C 
for 48 hours. Additional sodium ascorbate (374 equiv.) was added to the mixture after the first 24 
hours. The reaction mixture was then dialyzed first against EDTA solution (5g/L pH=7, 25000 
g/mol MWCO) for 12 hours with EDTA solution changed after the first 5 hours, and then against 
pure water overnight. The resulting aqueous mixture was lyophilized to yield the product 43L. 
Further characterization to follow in future work.
 
 
Synthesis of denpol 41D: 39D (40 mg, 0.02 mmol, 1 equiv.) and 7 (60 mg, 0.277 mmol, 16.5 
equiv.) were each dissolved in DMF (2 mL) and added to a flask. Sodium ascorbate (219 mg, 1.1 
mmol, 66 equiv.) was added as a solid powder. Copper sulfate (88 mg, 0.55 mmol, 33 equiv.) 
was added to the mixture as a solution in water (0.4 mL). Reaction mixture was stirred at 40  C 
for 48 hours. Additional sodium ascorbate (66 equiv.) was added to the mixture after the first 24 
hours. The reaction mixture was then dialyzed first against EDTA solution (5g/L pH=7, 1000 
g/mol MWCO) for 12 hours with EDTA solution changed after the first 5 hours, and then against 
pure water overnight. The resulting aqueous mixture was lyophilized to yield the product 41D. 
1
H NMR (D2O) δ: 8.14 (br, 1H), 5.39 (br, 1H), 4.89 (br, 2H), 4.11 (br, 3H), 3.85 (br, 2H), 3.70 
(br, 6H), 2.17 (s, 3H), 1.57 (br, 3H), 1.10 (br, 3H). Further characterization to follow in future 
work.
 
 
Synthesis of denpol 42D: 39D (7 mg, 0.002 mmol, 1 equiv.) and 7 (83 mg, 0.04 mmol, 16.5 
equiv.) were each dissolved in DMF (2 mL) and added to a flask. Sodium ascorbate (38 mg, 0.2 
mmol, 66 equiv.) was added as a solid powder. Copper sulfate (38 mg, 0.09 mmol, 33 equiv.) 
was added to the mixture as a solution in water (0.4 mL). Reaction mixture was stirred at 40  C 
for 48 hours. Additional sodium ascorbate (66 equiv.) was added to the mixture after the first 24 
hours. The reaction mixture was then dialyzed first against EDTA solution (5g/L pH=7, 2000 
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g/mol MWCO) for 12 hours with EDTA solution changed after the first 5 hours, and then against 
pure water overnight. The resulting aqueous mixture was lyophilized to yield the product 42D. 
Further characterization to follow in future work.
 
 
Synthesis of denpol 43D: 39D (5 mg, 0.002 mmol, 1 equiv.) and 7 (121 mg, 0.03 mmol, 16.5 
equiv.) were each dissolved in DMF (2 mL) and added to a flask. Sodium ascorbate (27 mg, 0.13 
mmol, 66 equiv.) was added as a solid powder. Copper sulfate (11 mg, 0.06 mmol, 33 equiv.) 
was added to the mixture as a solution in water (0.4 mL). Reaction mixture was stirred at 40  C 
for 48 hours. Additional sodium ascorbate (66 equiv.) was added to the mixture after the first 24 
hours. The reaction mixture was then dialyzed first against EDTA solution (5g/L pH=7, 6000-
8000 g/mol MWCO) for 12 hours with EDTA solution changed after the first 5 hours, and then 
against pure water overnight. The resulting aqueous mixture was lyophilized to yield the product 
43D. Further characterization to follow in future work.
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This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or one of
its group companies (each a"Wiley Company") or handled on behalf of a society with which a
Wiley Company has exclusive publishing rights in relation to a particular work (collectively
"WILEY"). By clicking �accept� in connection with completing this licensing transaction, you
agree that the following terms and conditions apply to this transaction (along with the billing and
payment terms and conditions established by the Copyright Clearance Center Inc., ("CCC's Billing
and Payment terms and conditions"), at the time that you opened your Rightslink account (these are
available at any time at http://myaccount.copyright.com).
Terms and Conditions
The materials you have requested permission to reproduce or reuse (the "Wiley Materials")
are protected by copyright. 
You are hereby granted a personal, non-exclusive, non-sub licensable (on a stand-alone
basis), non-transferable, worldwide, limited license to reproduce the Wiley Materials for the
purpose specified in the licensing process. This license is for a one-time use only and limited
to any maximum distribution number specified in the license. The first instance of
republication or reuse granted by this licence must be completed within two years of the date
of the grant of this licence (although copies prepared before the end date may be distributed
thereafter). The Wiley Materials shall not be used in any other manner or for any other
purpose, beyond what is granted in the license. Permission is granted subject to an
appropriate acknowledgement given to the author, title of the material/book/journal and the
publisher. You shall also duplicate the copyright notice that appears in the Wiley publication
in your use of the Wiley Material. Permission is also granted on the understanding that
nowhere in the text is a previously published source acknowledged for all or part of this
Wiley Material. Any third party content is expressly excluded from this permission.
With respect to the Wiley Materials, all rights are reserved. Except as expressly granted by
the terms of the license, no part of the Wiley Materials may be copied, modified, adapted
(except for minor reformatting required by the new Publication), translated, reproduced,
transferred or distributed, in any form or by any means, and no derivative works may be
made based on the Wiley Materials without the prior permission of the respective copyright
owner. You may not alter, remove or suppress in any manner any copyright, trademark or
other notices displayed by the Wiley Materials. You may not license, rent, sell, loan, lease,
pledge, offer as security, transfer or assign the Wiley Materials on a stand-alone basis, or
any of the rights granted to you hereunder to any other person.
The Wiley Materials and all of the intellectual property rights therein shall at all times remain
the exclusive property of John Wiley & Sons Inc, the Wiley Companies, or their respective
licensors, and your interest therein is only that of having possession of and the right to
reproduce the Wiley Materials pursuant to Section 2 herein during the continuance of this
Agreement. You agree that you own no right, title or interest in or to the Wiley Materials or
any of the intellectual property rights therein. You shall have no rights hereunder other than
the license as provided for above in Section 2. No right, license or interest to any trademark,
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trade name, service mark or other branding ("Marks") of WILEY or its licensors is granted
hereunder, and you agree that you shall not assert any such right, license or interest with
respect thereto. 
NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR
REPRESENTATION OF ANY KIND TO YOU OR ANY THIRD PARTY, EXPRESS,
IMPLIED OR STATUTORY, WITH RESPECT TO THE MATERIALS OR THE
ACCURACY OF ANY INFORMATION CONTAINED IN THE MATERIALS,
INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTY OF
MERCHANTABILITY, ACCURACY, SATISFACTORY QUALITY, FITNESS FOR
A PARTICULAR PURPOSE, USABILITY, INTEGRATION OR NON-
INFRINGEMENT AND ALL SUCH WARRANTIES ARE HEREBY EXCLUDED BY
WILEY AND ITS LICENSORS AND WAIVED BY YOU
WILEY shall have the right to terminate this Agreement immediately upon breach of this
Agreement by you.
You shall indemnify, defend and hold harmless WILEY, its Licensors and their respective
directors, officers, agents and employees, from and against any actual or threatened claims,
demands, causes of action or proceedings arising from any breach of this Agreement by you.
IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR ANY
OTHER PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY SPECIAL,
CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY OR PUNITIVE
DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN CONNECTION
WITH THE DOWNLOADING, PROVISIONING, VIEWING OR USE OF THE
MATERIALS REGARDLESS OF THE FORM OF ACTION, WHETHER FOR
BREACH OF CONTRACT, BREACH OF WARRANTY, TORT, NEGLIGENCE,
INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT LIMITATION,
DAMAGES BASED ON LOSS OF PROFITS, DATA, FILES, USE, BUSINESS
OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND WHETHER OR NOT
THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY FAILURE OF
ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN. 
Should any provision of this Agreement be held by a court of competent jurisdiction to be
illegal, invalid, or unenforceable, that provision shall be deemed amended to achieve as
nearly as possible the same economic effect as the original provision, and the legality, validity
and enforceability of the remaining provisions of this Agreement shall not be affected or
impaired thereby. 
The failure of either party to enforce any term or condition of this Agreement shall not
constitute a waiver of either party's right to enforce each and every term and condition of this
Agreement. No breach under this agreement shall be deemed waived or excused by either
party unless such waiver or consent is in writing signed by the party granting such waiver or
consent. The waiver by or consent of a party to a breach of any provision of this Agreement
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shall not operate or be construed as a waiver of or consent to any other or subsequent
breach by such other party. 
This Agreement may not be assigned (including by operation of law or otherwise) by you
without WILEY's prior written consent.
Any fee required for this permission shall be non-refundable after thirty (30) days from
receipt by the CCC. 
These terms and conditions together with CCC�s Billing and Payment terms and conditions
(which are incorporated herein) form the entire agreement between you and WILEY
concerning this licensing transaction and (in the absence of fraud) supersedes all prior
agreements and representations of the parties, oral or written. This Agreement may not be
amended except in writing signed by both parties. This Agreement shall be binding upon and
inure to the benefit of the parties' successors, legal representatives, and authorized assigns. 
In the event of any conflict between your obligations established by these terms and
conditions and those established by CCC�s Billing and Payment terms and conditions,
these terms and conditions shall prevail. 
WILEY expressly reserves all rights not specifically granted in the combination of (i) the
license details provided by you and accepted in the course of this licensing transaction, (ii)
these terms and conditions and (iii) CCC�s Billing and Payment terms and conditions.
This Agreement will be void if the Type of Use, Format, Circulation, or Requestor Type was
misrepresented during the licensing process.
This Agreement shall be governed by and construed in accordance with the laws of the State
of New York, USA, without regards to such state�s conflict of law rules. Any legal action,
suit or proceeding arising out of or relating to these Terms and Conditions or the breach
thereof shall be instituted in a court of competent jurisdiction in New York County in the
State of New York in the United States of America and each party hereby consents and
submits to the personal jurisdiction of such court, waives any objection to venue in such
court and consents to service of process by registered or certified mail, return receipt
requested, at the last known address of such party. 
WILEY OPEN ACCESS TERMS AND CONDITIONS
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription journals
offering Online Open. Although most of the fully Open Access journals publish open access articles
under the terms of the Creative Commons Attribution (CC BY) License only, the subscription
journals and a few of the Open Access Journals offer a choice of Creative Commons Licenses::
Creative Commons Attribution (CC-BY) license Creative Commons Attribution Non-Commercial
(CC-BY-NC) license and Creative Commons Attribution Non-Commercial-NoDerivs (CC-BY-
NC-ND) License. The license type is clearly identified on the article.
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Copyright in any research article in a journal published as Open Access under a Creative
Commons License is retained by the author(s). Authors grant Wiley a license to publish the article
and identify itself as the original publisher. Authors also grant any third party the right to use the
article freely as long as its integrity is maintained and its original authors, citation details and
publisher are identified as follows: [Title of Article/Author/Journal Title and Volume/Issue.
Copyright (c) [year] [copyright owner as specified in the Journal]. Links to the final article on
Wiley�s website are encouraged where applicable.
The Creative Commons Attribution License
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and transmit
an article, adapt the article and make commercial use of the article. The CC-BY license permits
commercial and non-commercial re-use of an open access article, as long as the author is properly
attributed.
The Creative Commons Attribution License does not affect the moral rights of authors, including
without limitation the right not to have their work subjected to derogatory treatment. It also does
not affect any other rights held by authors or third parties in the article, including without limitation
the rights of privacy and publicity. Use of the article must not assert or imply, whether implicitly or
explicitly, any connection with, endorsement or sponsorship of such use by the author, publisher or
any other party associated with the article.
For any reuse or distribution, users must include the copyright notice and make clear to others that
the article is made available under a Creative Commons Attribution license, linking to the relevant
Creative Commons web page.
To the fullest extent permitted by applicable law, the article is made available as is and without
representation or warranties of any kind whether express, implied, statutory or otherwise and
including, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-
infringement, absence of defects, accuracy, or the presence or absence of errors.
Creative Commons Attribution Non-Commercial License
The Creative Commons Attribution Non-Commercial (CC-BY-NC) License permits use,
distribution and reproduction in any medium, provided the original work is properly cited and is not
used for commercial purposes.(see below)
Creative Commons Attribution-Non-Commercial-NoDerivs License
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND)
permits use, distribution and reproduction in any medium, provided the original work is properly
cited, is not used for commercial purposes and no modifications or adaptations are made. (see
below)
Use by non-commercial users
For non-commercial and non-promotional purposes, individual users may access, download, copy,
display and redistribute to colleagues Wiley Open Access articles, as well as adapt, translate, text-
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and data-mine the content subject to the following conditions:
The authors' moral rights are not compromised. These rights include the right of "paternity"
(also known as "attribution" - the right for the author to be identified as such) and "integrity"
(the right for the author not to have the work altered in such a way that the author's
reputation or integrity may be impugned). 
Where content in the article is identified as belonging to a third party, it is the obligation of
the user to ensure that any reuse complies with the copyright policies of the owner of that
content. 
If article content is copied, downloaded or otherwise reused for non-commercial research
and education purposes, a link to the appropriate bibliographic citation (authors, journal,
article title, volume, issue, page numbers, DOI and the link to the definitive published version
on Wiley Online Library) should be maintained. Copyright notices and disclaimers must
not be deleted. 
Any translations, for which a prior translation agreement with Wiley has not been agreed,
must prominently display the statement: "This is an unofficial translation of an article that
appeared in a Wiley publication. The publisher has not endorsed this translation." 
Use by commercial "for-profit" organisations
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes requires
further explicit permission from Wiley and will be subject to a fee. Commercial purposes include:
Copying or downloading of articles, or linking to such articles for further redistribution, sale
or licensing; 
Copying, downloading or posting by a site or service that incorporates advertising with such
content; 
The inclusion or incorporation of article content in other works or services (other than
normal quotations with an appropriate citation) that is then available for sale or licensing, for
a fee (for example, a compilation produced for marketing purposes, inclusion in a sales
pack) 
Use of article content (other than normal quotations with appropriate citation) by for-profit
organisations for promotional purposes 
Linking to article content in e-mails redistributed for promotional, marketing or educational
purposes; 
Use for the purposes of monetary reward by means of sale, resale, licence, loan, transfer or
other form of commercial exploitation such as marketing products 
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Print reprints of Wiley Open Access articles can be purchased from:
corporatesales@wiley.com 
Further details can be found on Wiley Online Library
http://olabout.wiley.com/WileyCDA/Section/id-410895.html
Other Terms and Conditions: 
v1.9
If you would like to pay for this license now, please remit this license along with your
payment made payable to "COPYRIGHT CLEARANCE CENTER" otherwise you will be
invoiced within 48 hours of the license date. Payment should be in the form of a check or
money order referencing your account number and this invoice number 501345626.
Once you receive your invoice for this order, you may pay your invoice by credit card.
Please follow instructions provided at that time.
Make Payment To:
Copyright Clearance Center
Dept 001
P.O. Box 843006
Boston, MA 02284-3006
For suggestions or comments regarding this order, contact RightsLink Customer Support:
customercare@copyright.com or +1-877-622-5543 (toll free in the US) or +1-978-646-
2777.
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable
license for your reference. No payment is required.
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Terms and Conditions
INTRODUCTION
1. The publisher for this copyrighted material is Elsevier.  By clicking "accept" in connection with
completing this licensing transaction, you agree that the following terms and conditions apply to this
transaction (along with the Billing and Payment terms and conditions established by Copyright
Clearance Center, Inc. ("CCC"), at the time that you opened your Rightslink account and that are
available at any time at http://myaccount.copyright.com).
GENERAL TERMS
2. Elsevier hereby grants you permission to reproduce the aforementioned material subject to the
terms and conditions indicated.
3. Acknowledgement: If any part of the material to be used (for example, figures) has appeared in
our publication with credit or acknowledgement to another source, permission must also be sought
from that source.  If such permission is not obtained then that material may not be included in your
publication/copies. Suitable acknowledgement to the source must be made, either as a footnote or
in a reference list at the end of your publication, as follows:
“Reprinted from Publication title, Vol /edition number, Author(s), Title of article / title of chapter,
Pages No., Copyright (Year), with permission from Elsevier [OR APPLICABLE SOCIETY
COPYRIGHT OWNER].” Also Lancet special credit - “Reprinted from The Lancet, Vol. number,
Author(s), Title of article, Pages No., Copyright (Year), with permission from Elsevier.”
4. Reproduction of this material is confined to the purpose and/or media for which permission is
hereby given.
5. Altering/Modifying Material: Not Permitted. However figures and illustrations may be
altered/adapted minimally to serve your work. Any other abbreviations, additions, deletions and/or
any other alterations shall be made only with prior written authorization of Elsevier Ltd. (Please
contact Elsevier at permissions@elsevier.com)
6. If the permission fee for the requested use of our material is waived in this instance, please be
advised that your future requests for Elsevier materials may attract a fee.
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7. Reservation of Rights: Publisher reserves all rights not specifically granted in the combination of
(i) the license details provided by you and accepted in the course of this licensing transaction, (ii)
these terms and conditions and (iii) CCC's Billing and Payment terms and conditions.
8. License Contingent Upon Payment: While you may exercise the rights licensed immediately upon
issuance of the license at the end of the licensing process for the transaction, provided that you have
disclosed complete and accurate details of your proposed use, no license is finally effective unless
and until full payment is received from you (either by publisher or by CCC) as provided in CCC's
Billing and Payment terms and conditions.  If full payment is not received on a timely basis, then any
license preliminarily granted shall be deemed automatically revoked and shall be void as if never
granted.  Further, in the event that you breach any of these terms and conditions or any of CCC's
Billing and Payment terms and conditions, the license is automatically revoked and shall be void as
if never granted.  Use of materials as described in a revoked license, as well as any use of the
materials beyond the scope of an unrevoked license, may constitute copyright infringement and
publisher reserves the right to take any and all action to protect its copyright in the materials.
9. Warranties: Publisher makes no representations or warranties with respect to the licensed
material.
10. Indemnity: You hereby indemnify and agree to hold harmless publisher and CCC, and their
respective officers, directors, employees and agents, from and against any and all claims arising out
of your use of the licensed material other than as specifically authorized pursuant to this license.
11. No Transfer of License: This license is personal to you and may not be sublicensed, assigned,
or transferred by you to any other person without publisher's written permission.
12. No Amendment Except in Writing: This license may not be amended except in a writing signed
by both parties (or, in the case of publisher, by CCC on publisher's behalf).
13. Objection to Contrary Terms: Publisher hereby objects to any terms contained in any purchase
order, acknowledgment, check endorsement or other writing prepared by you, which terms are
inconsistent with these terms and conditions or CCC's Billing and Payment terms and conditions. 
These terms and conditions, together with CCC's Billing and Payment terms and conditions (which
are incorporated herein), comprise the entire agreement between you and publisher (and CCC)
concerning this licensing transaction.  In the event of any conflict between your obligations
established by these terms and conditions and those established by CCC's Billing and Payment
terms and conditions, these terms and conditions shall control.
14. Revocation: Elsevier or Copyright Clearance Center may deny the permissions described in this
License at their sole discretion, for any reason or no reason, with a full refund payable to you. 
Notice of such denial will be made using the contact information provided by you.  Failure to
receive such notice will not alter or invalidate the denial.  In no event will Elsevier or Copyright
Clearance Center be responsible or liable for any costs, expenses or damage incurred by you as a
result of a denial of your permission request, other than a refund of the amount(s) paid by you to
Elsevier and/or Copyright Clearance Center for denied permissions.
LIMITED LICENSE
7/9/2014 Rightslink Printable License
https://s100.copyright.com/AppDispatchServlet 4/7
The following terms and conditions apply only to specific license types:
15. Translation: This permission is granted for non-exclusive world English rights only unless
your license was granted for translation rights. If you licensed translation rights you may only
translate this content into the languages you requested. A professional translator must perform all
translations and reproduce the content word for word preserving the integrity of the article. If this
license is to re-use 1 or 2 figures then permission is granted for non-exclusive world rights in all
languages.
16. Posting licensed content on any Website: The following terms and conditions apply as
follows: Licensing material from an Elsevier journal: All content posted to the web site must
maintain the copyright information line on the bottom of each image; A hyper-text must be included
to the Homepage of the journal from which you are licensing at
http://www.sciencedirect.com/science/journal/xxxxx or the Elsevier homepage for books at
http://www.elsevier.com; Central Storage: This license does not include permission for a scanned
version of the material to be stored in a central repository such as that provided by Heron/XanEdu.
Licensing material from an Elsevier book: A hyper-text link must be included to the Elsevier
homepage at http://www.elsevier.com . All content posted to the web site must maintain the
copyright information line on the bottom of each image.
Posting licensed content on Electronic reserve:  In addition to the above the following clauses
are applicable: The web site must be password-protected and made available only to bona fide
students registered on a relevant course. This permission is granted for 1 year only. You may obtain
a new license for future website posting.
For journal authors:  the following clauses are applicable in addition to the above: Permission
granted is limited to the author accepted manuscript version* of your paper.
*Accepted Author Manuscript (AAM) Definition: An accepted author manuscript (AAM) is
the author’s version of the manuscript of an article that has been accepted for publication and which
may include any author-incorporated changes suggested through the processes of submission
processing, peer review, and editor-author communications. AAMs do not include other publisher
value-added contributions such as copy-editing, formatting, technical enhancements and (if
relevant) pagination.
You are not allowed to download and post the published journal article (whether PDF or HTML,
proof or final version), nor may you scan the printed edition to create an electronic version. A
hyper-text must be included to the Homepage of the journal from which you are licensing at
http://www.sciencedirect.com/science/journal/xxxxx. As part of our normal production process,
you will receive an e-mail notice when your article appears on Elsevier’s online service
ScienceDirect (www.sciencedirect.com). That e-mail will include the article’s Digital Object
Identifier (DOI). This number provides the electronic link to the published article and should be
included in the posting of your personal version. We ask that you wait until you receive this e-mail
and have the DOI to do any posting.
Posting to a repository: Authors may post their AAM immediately to their employer’s
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institutional repository for internal use only and may make their manuscript publically available after
the journal-specific embargo period has ended.
Please also refer to Elsevier's Article Posting Policy for further information.
18. For book authors the following clauses are applicable in addition to the above:   Authors are
permitted to place a brief summary of their work online only.. You are not allowed to download
and post the published electronic version of your chapter, nor may you scan the printed edition to
create an electronic version. Posting to a repository: Authors are permitted to post a summary of
their chapter only in their institution’s repository.
20. Thesis/Dissertation: If your license is for use in a thesis/dissertation your thesis may be
submitted to your institution in either print or electronic form. Should your thesis be published
commercially, please reapply for permission. These requirements include permission for the Library
and Archives of Canada to supply single copies, on demand, of the complete thesis and include
permission for UMI to supply single copies, on demand, of the complete thesis. Should your thesis
be published commercially, please reapply for permission.
 
Elsevier Open Access Terms and Conditions
Elsevier publishes Open Access articles in both its Open Access journals and via its Open Access
articles option in subscription journals.
Authors publishing in an Open Access journal or who choose to make their article Open Access in
an Elsevier subscription journal select one of the following Creative Commons user licenses, which
define how a reader may reuse their work: Creative Commons Attribution License (CC BY),
Creative Commons Attribution – Non Commercial - ShareAlike (CC BY NC SA) and Creative
Commons Attribution – Non Commercial – No Derivatives (CC BY NC ND)
Terms & Conditions applicable to all Elsevier Open Access articles:
Any reuse of the article must not represent the author as endorsing the adaptation of the article nor
should the article be modified in such a way as to damage the author’s honour or reputation.
The author(s) must be appropriately credited.
If any part of the material to be used (for example, figures) has appeared in our publication with
credit or acknowledgement to another source it is the responsibility of the user to ensure their reuse
complies with the terms and conditions determined by the rights holder.
Additional Terms & Conditions applicable to each Creative Commons user license:
CC BY: You may distribute and copy the article, create extracts, abstracts, and other revised
versions, adaptations or derivative works of or from an article (such as a translation), to include in a
collective work (such as an anthology), to text or data mine the article, including for commercial
purposes without permission from Elsevier
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CC BY NC SA: For non-commercial purposes you may distribute and copy the article, create
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the article and license new adaptations or creations under identical terms without permission from
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CC BY NC ND: For non-commercial purposes you may distribute and copy the article and
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article, without permission from Elsevier
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ND license requires permission from Elsevier and will be subject to a fee.
Commercial reuse includes:
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·         Commercial exploitation ( e.g. a product for sale or loan)
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money order referencing your account number and this invoice number 501346900.
Once you receive your invoice for this order, you may pay your invoice by credit card.
Please follow instructions provided at that time.
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Terms and Conditions
INTRODUCTION
1. The publisher for this copyrighted material is Elsevier.  By clicking "accept" in connection with
completing this licensing transaction, you agree that the following terms and conditions apply to this
transaction (along with the Billing and Payment terms and conditions established by Copyright
Clearance Center, Inc. ("CCC"), at the time that you opened your Rightslink account and that are
available at any time at http://myaccount.copyright.com).
GENERAL TERMS
2. Elsevier hereby grants you permission to reproduce the aforementioned material subject to the
terms and conditions indicated.
3. Acknowledgement: If any part of the material to be used (for example, figures) has appeared in
our publication with credit or acknowledgement to another source, permission must also be sought
from that source.  If such permission is not obtained then that material may not be included in your
publication/copies. Suitable acknowledgement to the source must be made, either as a footnote or
in a reference list at the end of your publication, as follows:
“Reprinted from Publication title, Vol /edition number, Author(s), Title of article / title of chapter,
Pages No., Copyright (Year), with permission from Elsevier [OR APPLICABLE SOCIETY
COPYRIGHT OWNER].” Also Lancet special credit - “Reprinted from The Lancet, Vol. number,
Author(s), Title of article, Pages No., Copyright (Year), with permission from Elsevier.”
4. Reproduction of this material is confined to the purpose and/or media for which permission is
hereby given.
5. Altering/Modifying Material: Not Permitted. However figures and illustrations may be
altered/adapted minimally to serve your work. Any other abbreviations, additions, deletions and/or
any other alterations shall be made only with prior written authorization of Elsevier Ltd. (Please
contact Elsevier at permissions@elsevier.com)
6. If the permission fee for the requested use of our material is waived in this instance, please be
advised that your future requests for Elsevier materials may attract a fee.
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7. Reservation of Rights: Publisher reserves all rights not specifically granted in the combination of
(i) the license details provided by you and accepted in the course of this licensing transaction, (ii)
these terms and conditions and (iii) CCC's Billing and Payment terms and conditions.
8. License Contingent Upon Payment: While you may exercise the rights licensed immediately upon
issuance of the license at the end of the licensing process for the transaction, provided that you have
disclosed complete and accurate details of your proposed use, no license is finally effective unless
and until full payment is received from you (either by publisher or by CCC) as provided in CCC's
Billing and Payment terms and conditions.  If full payment is not received on a timely basis, then any
license preliminarily granted shall be deemed automatically revoked and shall be void as if never
granted.  Further, in the event that you breach any of these terms and conditions or any of CCC's
Billing and Payment terms and conditions, the license is automatically revoked and shall be void as
if never granted.  Use of materials as described in a revoked license, as well as any use of the
materials beyond the scope of an unrevoked license, may constitute copyright infringement and
publisher reserves the right to take any and all action to protect its copyright in the materials.
9. Warranties: Publisher makes no representations or warranties with respect to the licensed
material.
10. Indemnity: You hereby indemnify and agree to hold harmless publisher and CCC, and their
respective officers, directors, employees and agents, from and against any and all claims arising out
of your use of the licensed material other than as specifically authorized pursuant to this license.
11. No Transfer of License: This license is personal to you and may not be sublicensed, assigned,
or transferred by you to any other person without publisher's written permission.
12. No Amendment Except in Writing: This license may not be amended except in a writing signed
by both parties (or, in the case of publisher, by CCC on publisher's behalf).
13. Objection to Contrary Terms: Publisher hereby objects to any terms contained in any purchase
order, acknowledgment, check endorsement or other writing prepared by you, which terms are
inconsistent with these terms and conditions or CCC's Billing and Payment terms and conditions. 
These terms and conditions, together with CCC's Billing and Payment terms and conditions (which
are incorporated herein), comprise the entire agreement between you and publisher (and CCC)
concerning this licensing transaction.  In the event of any conflict between your obligations
established by these terms and conditions and those established by CCC's Billing and Payment
terms and conditions, these terms and conditions shall control.
14. Revocation: Elsevier or Copyright Clearance Center may deny the permissions described in this
License at their sole discretion, for any reason or no reason, with a full refund payable to you. 
Notice of such denial will be made using the contact information provided by you.  Failure to
receive such notice will not alter or invalidate the denial.  In no event will Elsevier or Copyright
Clearance Center be responsible or liable for any costs, expenses or damage incurred by you as a
result of a denial of your permission request, other than a refund of the amount(s) paid by you to
Elsevier and/or Copyright Clearance Center for denied permissions.
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The following terms and conditions apply only to specific license types:
15. Translation: This permission is granted for non-exclusive world English rights only unless
your license was granted for translation rights. If you licensed translation rights you may only
translate this content into the languages you requested. A professional translator must perform all
translations and reproduce the content word for word preserving the integrity of the article. If this
license is to re-use 1 or 2 figures then permission is granted for non-exclusive world rights in all
languages.
16. Posting licensed content on any Website: The following terms and conditions apply as
follows: Licensing material from an Elsevier journal: All content posted to the web site must
maintain the copyright information line on the bottom of each image; A hyper-text must be included
to the Homepage of the journal from which you are licensing at
http://www.sciencedirect.com/science/journal/xxxxx or the Elsevier homepage for books at
http://www.elsevier.com; Central Storage: This license does not include permission for a scanned
version of the material to be stored in a central repository such as that provided by Heron/XanEdu.
Licensing material from an Elsevier book: A hyper-text link must be included to the Elsevier
homepage at http://www.elsevier.com . All content posted to the web site must maintain the
copyright information line on the bottom of each image.
Posting licensed content on Electronic reserve:  In addition to the above the following clauses
are applicable: The web site must be password-protected and made available only to bona fide
students registered on a relevant course. This permission is granted for 1 year only. You may obtain
a new license for future website posting.
For journal authors:  the following clauses are applicable in addition to the above: Permission
granted is limited to the author accepted manuscript version* of your paper.
*Accepted Author Manuscript (AAM) Definition: An accepted author manuscript (AAM) is
the author’s version of the manuscript of an article that has been accepted for publication and which
may include any author-incorporated changes suggested through the processes of submission
processing, peer review, and editor-author communications. AAMs do not include other publisher
value-added contributions such as copy-editing, formatting, technical enhancements and (if
relevant) pagination.
You are not allowed to download and post the published journal article (whether PDF or HTML,
proof or final version), nor may you scan the printed edition to create an electronic version. A
hyper-text must be included to the Homepage of the journal from which you are licensing at
http://www.sciencedirect.com/science/journal/xxxxx. As part of our normal production process,
you will receive an e-mail notice when your article appears on Elsevier’s online service
ScienceDirect (www.sciencedirect.com). That e-mail will include the article’s Digital Object
Identifier (DOI). This number provides the electronic link to the published article and should be
included in the posting of your personal version. We ask that you wait until you receive this e-mail
and have the DOI to do any posting.
Posting to a repository: Authors may post their AAM immediately to their employer’s
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institutional repository for internal use only and may make their manuscript publically available after
the journal-specific embargo period has ended.
Please also refer to Elsevier's Article Posting Policy for further information.
18. For book authors the following clauses are applicable in addition to the above:   Authors are
permitted to place a brief summary of their work online only.. You are not allowed to download
and post the published electronic version of your chapter, nor may you scan the printed edition to
create an electronic version. Posting to a repository: Authors are permitted to post a summary of
their chapter only in their institution’s repository.
20. Thesis/Dissertation: If your license is for use in a thesis/dissertation your thesis may be
submitted to your institution in either print or electronic form. Should your thesis be published
commercially, please reapply for permission. These requirements include permission for the Library
and Archives of Canada to supply single copies, on demand, of the complete thesis and include
permission for UMI to supply single copies, on demand, of the complete thesis. Should your thesis
be published commercially, please reapply for permission.
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Authors publishing in an Open Access journal or who choose to make their article Open Access in
an Elsevier subscription journal select one of the following Creative Commons user licenses, which
define how a reader may reuse their work: Creative Commons Attribution License (CC BY),
Creative Commons Attribution – Non Commercial - ShareAlike (CC BY NC SA) and Creative
Commons Attribution – Non Commercial – No Derivatives (CC BY NC ND)
Terms & Conditions applicable to all Elsevier Open Access articles:
Any reuse of the article must not represent the author as endorsing the adaptation of the article nor
should the article be modified in such a way as to damage the author’s honour or reputation.
The author(s) must be appropriately credited.
If any part of the material to be used (for example, figures) has appeared in our publication with
credit or acknowledgement to another source it is the responsibility of the user to ensure their reuse
complies with the terms and conditions determined by the rights holder.
Additional Terms & Conditions applicable to each Creative Commons user license:
CC BY: You may distribute and copy the article, create extracts, abstracts, and other revised
versions, adaptations or derivative works of or from an article (such as a translation), to include in a
collective work (such as an anthology), to text or data mine the article, including for commercial
purposes without permission from Elsevier
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CC BY NC ND: For non-commercial purposes you may distribute and copy the article and
include it in a collective work (such as an anthology), provided you do not alter or modify the
article, without permission from Elsevier
Any commercial reuse of Open Access articles published with a CC BY NC SA or CC BY NC
ND license requires permission from Elsevier and will be subject to a fee.
Commercial reuse includes:
·         Promotional purposes (advertising or marketing)
·         Commercial exploitation ( e.g. a product for sale or loan)
·         Systematic distribution (for a fee or free of charge)
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Please follow instructions provided at that time.
Make Payment To:
Copyright Clearance Center
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P.O. Box 843006
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This is a License Agreement between Namrata Jain ("You") and Springer ("Springer") provided by
Copyright Clearance Center ("CCC"). The license consists of your order details, the terms and
conditions provided by Springer, and the payment terms and conditions.
All payments must be made in full to CCC. For payment instructions, please see
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Licensed content title Carbohydrate–protein interactions and their biosensing
applications
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Terms and Conditions
Introduction
The publisher for this copyrighted material is Springer Science + Business Media. By clicking
"accept" in connection with completing this licensing transaction, you agree that the following terms
and conditions apply to this transaction (along with the Billing and Payment terms and conditions
established by Copyright Clearance Center, Inc. ("CCC"), at the time that you opened your
Rightslink account and that are available at any time at http://myaccount.copyright.com).
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Limited License
With reference to your request to reprint in your thesis material on which Springer Science and
Business Media control the copyright, permission is granted, free of charge, for the use indicated in
your enquiry.
Licenses are for one-time use only with a maximum distribution equal to the number that you
identified in the licensing process.
This License includes use in an electronic form, provided its password protected or on the
university’s intranet or repository, including UMI (according to the definition at the Sherpa website:
http://www.sherpa.ac.uk/romeo/). For any other electronic use, please contact Springer at
(permissions.dordrecht@springer.com or permissions.heidelberg@springer.com).
The material can only be used for the purpose of defending your thesis limited to university-use
only. If the thesis is going to be published, permission needs to be re-obtained (selecting
"book/textbook" as the type of use).
Although Springer holds copyright to the material and is entitled to negotiate on rights, this license is
only valid, subject to a courtesy information to the author (address is given with the article/chapter)
and provided it concerns original material which does not carry references to other sources (if
material in question appears with credit to another source, authorization from that source is required
as well).
Permission free of charge on this occasion does not prejudice any rights we might have to charge
for reproduction of our copyrighted material in the future.
Altering/Modifying Material: Not Permitted
You may not alter or modify the material in any manner. Abbreviations, additions, deletions and/or
any other alterations shall be made only with prior written authorization of the author(s) and/or
Springer Science + Business Media. (Please contact Springer at
(permissions.dordrecht@springer.com or permissions.heidelberg@springer.com)
Reservation of Rights
Springer Science + Business Media reserves all rights not specifically granted in the combination of
(i) the license details provided by you and accepted in the course of this licensing transaction, (ii)
these terms and conditions and (iii) CCC's Billing and Payment terms and conditions.
Copyright Notice:Disclaimer
You must include the following copyright and permission notice in connection with any reproduction
of the licensed material: "Springer and the original publisher /journal title, volume, year of
publication, page, chapter/article title, name(s) of author(s), figure number(s), original copyright
notice) is given to the publication in which the material was originally published, by adding; with
kind permission from Springer Science and Business Media"
Warranties: None
Example 1: Springer Science + Business Media makes no representations or warranties with
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respect to the licensed material.
Example 2: Springer Science + Business Media makes no representations or warranties with
respect to the licensed material and adopts on its own behalf the limitations and disclaimers
established by CCC on its behalf in its Billing and Payment terms and conditions for this licensing
transaction.
Indemnity
You hereby indemnify and agree to hold harmless Springer Science + Business Media and CCC,
and their respective officers, directors, employees and agents, from and against any and all claims
arising out of your use of the licensed material other than as specifically authorized pursuant to this
license.
No Transfer of License
This license is personal to you and may not be sublicensed, assigned, or transferred by you to any
other person without Springer Science + Business Media's written permission.
No Amendment Except in Writing
This license may not be amended except in a writing signed by both parties (or, in the case of
Springer Science + Business Media, by CCC on Springer Science + Business Media's behalf).
Objection to Contrary Terms
Springer Science + Business Media hereby objects to any terms contained in any purchase order,
acknowledgment, check endorsement or other writing prepared by you, which terms are
inconsistent with these terms and conditions or CCC's Billing and Payment terms and conditions.
These terms and conditions, together with CCC's Billing and Payment terms and conditions (which
are incorporated herein), comprise the entire agreement between you and Springer Science +
Business Media (and CCC) concerning this licensing transaction. In the event of any conflict
between your obligations established by these terms and conditions and those established by
CCC's Billing and Payment terms and conditions, these terms and conditions shall control.
Jurisdiction
All disputes that may arise in connection with this present License, or the breach thereof, shall be
settled exclusively by arbitration, to be held in The Netherlands, in accordance with Dutch law, and
to be conducted under the Rules of the 'Netherlands Arbitrage Instituut' (Netherlands Institute of
Arbitration).OR:
All disputes that may arise in connection with this present License, or the breach thereof,
shall be settled exclusively by arbitration, to be held in the Federal Republic of Germany,
in accordance with German law.
Other terms and conditions:
v1.3
You will be invoiced within 48 hours of this transaction date. You may pay your invoice by
credit card upon receipt of the invoice for this transaction. Please follow instructions
provided at that time. 
To pay for this transaction now; please remit a copy of this document along with your
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payment. Payment should be in the form of a check or money order referencing your
account number and this invoice number RLNK501364694.
Make payments to "COPYRIGHT CLEARANCE CENTER" and send to: 
Copyright Clearance Center
Dept 001
P.O. Box 843006
Boston, MA 02284-3006
Please disregard electronic and mailed copies if you remit payment in advance.
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or
+1-978-646-2777.
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable
license for your reference. No payment is required.
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details, the terms and conditions provided by John Wiley and Sons, and the payment terms and
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All payments must be made in full to CCC. For payment instructions, please see
information listed at the bottom of this form.
License Number 3438920826162
License date Jul 30, 2014
Licensed content publisher John Wiley and Sons
Licensed content
publication
Angewandte Chemie International Edition
Licensed content title Extremely Long Dendronized Polymers: Synthesis, Quantification
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Licensed copyright line Copyright © 2001 WILEY-VCH Verlag GmbH, Weinheim, Fed. Rep.
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Licensed content author Lijin Shu,A. Dieter Schlüter,Christof Ecker,Nikolai Severin,Jürgen P.
Rabe
Licensed content date Dec 18, 2001
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Type of use Dissertation/Thesis
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Number of figures/tables 1
Original Wiley figure/table
number(s)
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TERMS AND CONDITIONS
This copyrighted material is owned by or exclusively licensed to John Wiley & Sons, Inc. or one of
its group companies (each a"Wiley Company") or handled on behalf of a society with which a
Wiley Company has exclusive publishing rights in relation to a particular work (collectively
"WILEY"). By clicking �accept� in connection with completing this licensing transaction, you
agree that the following terms and conditions apply to this transaction (along with the billing and
payment terms and conditions established by the Copyright Clearance Center Inc., ("CCC's Billing
and Payment terms and conditions"), at the time that you opened your Rightslink account (these are
available at any time at http://myaccount.copyright.com).
Terms and Conditions
The materials you have requested permission to reproduce or reuse (the "Wiley Materials")
are protected by copyright. 
You are hereby granted a personal, non-exclusive, non-sub licensable (on a stand-alone
basis), non-transferable, worldwide, limited license to reproduce the Wiley Materials for the
purpose specified in the licensing process. This license is for a one-time use only and limited
to any maximum distribution number specified in the license. The first instance of
republication or reuse granted by this licence must be completed within two years of the date
of the grant of this licence (although copies prepared before the end date may be distributed
thereafter). The Wiley Materials shall not be used in any other manner or for any other
purpose, beyond what is granted in the license. Permission is granted subject to an
appropriate acknowledgement given to the author, title of the material/book/journal and the
publisher. You shall also duplicate the copyright notice that appears in the Wiley publication
in your use of the Wiley Material. Permission is also granted on the understanding that
nowhere in the text is a previously published source acknowledged for all or part of this
Wiley Material. Any third party content is expressly excluded from this permission.
With respect to the Wiley Materials, all rights are reserved. Except as expressly granted by
the terms of the license, no part of the Wiley Materials may be copied, modified, adapted
(except for minor reformatting required by the new Publication), translated, reproduced,
transferred or distributed, in any form or by any means, and no derivative works may be
made based on the Wiley Materials without the prior permission of the respective copyright
owner. You may not alter, remove or suppress in any manner any copyright, trademark or
other notices displayed by the Wiley Materials. You may not license, rent, sell, loan, lease,
pledge, offer as security, transfer or assign the Wiley Materials on a stand-alone basis, or
any of the rights granted to you hereunder to any other person.
The Wiley Materials and all of the intellectual property rights therein shall at all times remain
the exclusive property of John Wiley & Sons Inc, the Wiley Companies, or their respective
licensors, and your interest therein is only that of having possession of and the right to
reproduce the Wiley Materials pursuant to Section 2 herein during the continuance of this
Agreement. You agree that you own no right, title or interest in or to the Wiley Materials or
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any of the intellectual property rights therein. You shall have no rights hereunder other than
the license as provided for above in Section 2. No right, license or interest to any trademark,
trade name, service mark or other branding ("Marks") of WILEY or its licensors is granted
hereunder, and you agree that you shall not assert any such right, license or interest with
respect thereto. 
NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR
REPRESENTATION OF ANY KIND TO YOU OR ANY THIRD PARTY, EXPRESS,
IMPLIED OR STATUTORY, WITH RESPECT TO THE MATERIALS OR THE
ACCURACY OF ANY INFORMATION CONTAINED IN THE MATERIALS,
INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTY OF
MERCHANTABILITY, ACCURACY, SATISFACTORY QUALITY, FITNESS FOR
A PARTICULAR PURPOSE, USABILITY, INTEGRATION OR NON-
INFRINGEMENT AND ALL SUCH WARRANTIES ARE HEREBY EXCLUDED BY
WILEY AND ITS LICENSORS AND WAIVED BY YOU
WILEY shall have the right to terminate this Agreement immediately upon breach of this
Agreement by you.
You shall indemnify, defend and hold harmless WILEY, its Licensors and their respective
directors, officers, agents and employees, from and against any actual or threatened claims,
demands, causes of action or proceedings arising from any breach of this Agreement by you.
IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR ANY
OTHER PARTY OR ANY OTHER PERSON OR ENTITY FOR ANY SPECIAL,
CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY OR PUNITIVE
DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN CONNECTION
WITH THE DOWNLOADING, PROVISIONING, VIEWING OR USE OF THE
MATERIALS REGARDLESS OF THE FORM OF ACTION, WHETHER FOR
BREACH OF CONTRACT, BREACH OF WARRANTY, TORT, NEGLIGENCE,
INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT LIMITATION,
DAMAGES BASED ON LOSS OF PROFITS, DATA, FILES, USE, BUSINESS
OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND WHETHER OR NOT
THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
THIS LIMITATION SHALL APPLY NOTWITHSTANDING ANY FAILURE OF
ESSENTIAL PURPOSE OF ANY LIMITED REMEDY PROVIDED HEREIN. 
Should any provision of this Agreement be held by a court of competent jurisdiction to be
illegal, invalid, or unenforceable, that provision shall be deemed amended to achieve as
nearly as possible the same economic effect as the original provision, and the legality, validity
and enforceability of the remaining provisions of this Agreement shall not be affected or
impaired thereby. 
The failure of either party to enforce any term or condition of this Agreement shall not
constitute a waiver of either party's right to enforce each and every term and condition of this
Agreement. No breach under this agreement shall be deemed waived or excused by either
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party unless such waiver or consent is in writing signed by the party granting such waiver or
consent. The waiver by or consent of a party to a breach of any provision of this Agreement
shall not operate or be construed as a waiver of or consent to any other or subsequent
breach by such other party. 
This Agreement may not be assigned (including by operation of law or otherwise) by you
without WILEY's prior written consent.
Any fee required for this permission shall be non-refundable after thirty (30) days from
receipt by the CCC. 
These terms and conditions together with CCC�s Billing and Payment terms and conditions
(which are incorporated herein) form the entire agreement between you and WILEY
concerning this licensing transaction and (in the absence of fraud) supersedes all prior
agreements and representations of the parties, oral or written. This Agreement may not be
amended except in writing signed by both parties. This Agreement shall be binding upon and
inure to the benefit of the parties' successors, legal representatives, and authorized assigns. 
In the event of any conflict between your obligations established by these terms and
conditions and those established by CCC�s Billing and Payment terms and conditions,
these terms and conditions shall prevail. 
WILEY expressly reserves all rights not specifically granted in the combination of (i) the
license details provided by you and accepted in the course of this licensing transaction, (ii)
these terms and conditions and (iii) CCC�s Billing and Payment terms and conditions.
This Agreement will be void if the Type of Use, Format, Circulation, or Requestor Type was
misrepresented during the licensing process.
This Agreement shall be governed by and construed in accordance with the laws of the State
of New York, USA, without regards to such state�s conflict of law rules. Any legal action,
suit or proceeding arising out of or relating to these Terms and Conditions or the breach
thereof shall be instituted in a court of competent jurisdiction in New York County in the
State of New York in the United States of America and each party hereby consents and
submits to the personal jurisdiction of such court, waives any objection to venue in such
court and consents to service of process by registered or certified mail, return receipt
requested, at the last known address of such party. 
WILEY OPEN ACCESS TERMS AND CONDITIONS
Wiley Publishes Open Access Articles in fully Open Access Journals and in Subscription journals
offering Online Open. Although most of the fully Open Access journals publish open access articles
under the terms of the Creative Commons Attribution (CC BY) License only, the subscription
journals and a few of the Open Access Journals offer a choice of Creative Commons Licenses::
Creative Commons Attribution (CC-BY) license Creative Commons Attribution Non-Commercial
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(CC-BY-NC) license and Creative Commons Attribution Non-Commercial-NoDerivs (CC-BY-
NC-ND) License. The license type is clearly identified on the article.
Copyright in any research article in a journal published as Open Access under a Creative
Commons License is retained by the author(s). Authors grant Wiley a license to publish the article
and identify itself as the original publisher. Authors also grant any third party the right to use the
article freely as long as its integrity is maintained and its original authors, citation details and
publisher are identified as follows: [Title of Article/Author/Journal Title and Volume/Issue.
Copyright (c) [year] [copyright owner as specified in the Journal]. Links to the final article on
Wiley�s website are encouraged where applicable.
The Creative Commons Attribution License
The Creative Commons Attribution License (CC-BY) allows users to copy, distribute and transmit
an article, adapt the article and make commercial use of the article. The CC-BY license permits
commercial and non-commercial re-use of an open access article, as long as the author is properly
attributed.
The Creative Commons Attribution License does not affect the moral rights of authors, including
without limitation the right not to have their work subjected to derogatory treatment. It also does
not affect any other rights held by authors or third parties in the article, including without limitation
the rights of privacy and publicity. Use of the article must not assert or imply, whether implicitly or
explicitly, any connection with, endorsement or sponsorship of such use by the author, publisher or
any other party associated with the article.
For any reuse or distribution, users must include the copyright notice and make clear to others that
the article is made available under a Creative Commons Attribution license, linking to the relevant
Creative Commons web page.
To the fullest extent permitted by applicable law, the article is made available as is and without
representation or warranties of any kind whether express, implied, statutory or otherwise and
including, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-
infringement, absence of defects, accuracy, or the presence or absence of errors.
Creative Commons Attribution Non-Commercial License
The Creative Commons Attribution Non-Commercial (CC-BY-NC) License permits use,
distribution and reproduction in any medium, provided the original work is properly cited and is not
used for commercial purposes.(see below)
Creative Commons Attribution-Non-Commercial-NoDerivs License
The Creative Commons Attribution Non-Commercial-NoDerivs License (CC-BY-NC-ND)
permits use, distribution and reproduction in any medium, provided the original work is properly
cited, is not used for commercial purposes and no modifications or adaptations are made. (see
below)
Use by non-commercial users
7/30/2014 Rightslink Printable License
https://s100.copyright.com/AppDispatchServlet 6/7
For non-commercial and non-promotional purposes, individual users may access, download, copy,
display and redistribute to colleagues Wiley Open Access articles, as well as adapt, translate, text-
and data-mine the content subject to the following conditions:
The authors' moral rights are not compromised. These rights include the right of "paternity"
(also known as "attribution" - the right for the author to be identified as such) and "integrity"
(the right for the author not to have the work altered in such a way that the author's
reputation or integrity may be impugned). 
Where content in the article is identified as belonging to a third party, it is the obligation of
the user to ensure that any reuse complies with the copyright policies of the owner of that
content. 
If article content is copied, downloaded or otherwise reused for non-commercial research
and education purposes, a link to the appropriate bibliographic citation (authors, journal,
article title, volume, issue, page numbers, DOI and the link to the definitive published version
on Wiley Online Library) should be maintained. Copyright notices and disclaimers must
not be deleted. 
Any translations, for which a prior translation agreement with Wiley has not been agreed,
must prominently display the statement: "This is an unofficial translation of an article that
appeared in a Wiley publication. The publisher has not endorsed this translation." 
Use by commercial "for-profit" organisations
Use of Wiley Open Access articles for commercial, promotional, or marketing purposes requires
further explicit permission from Wiley and will be subject to a fee. Commercial purposes include:
Copying or downloading of articles, or linking to such articles for further redistribution, sale
or licensing; 
Copying, downloading or posting by a site or service that incorporates advertising with such
content; 
The inclusion or incorporation of article content in other works or services (other than
normal quotations with an appropriate citation) that is then available for sale or licensing, for
a fee (for example, a compilation produced for marketing purposes, inclusion in a sales
pack) 
Use of article content (other than normal quotations with appropriate citation) by for-profit
organisations for promotional purposes 
Linking to article content in e-mails redistributed for promotional, marketing or educational
purposes; 
Use for the purposes of monetary reward by means of sale, resale, licence, loan, transfer or
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other form of commercial exploitation such as marketing products 
Print reprints of Wiley Open Access articles can be purchased from:
corporatesales@wiley.com 
Further details can be found on Wiley Online Library
http://olabout.wiley.com/WileyCDA/Section/id-410895.html
Other Terms and Conditions: 
v1.9
You will be invoiced within 48 hours of this transaction date. You may pay your invoice by
credit card upon receipt of the invoice for this transaction. Please follow instructions
provided at that time. 
To pay for this transaction now; please remit a copy of this document along with your
payment. Payment should be in the form of a check or money order referencing your
account number and this invoice number RLNK501365432.
Make payments to "COPYRIGHT CLEARANCE CENTER" and send to: 
Copyright Clearance Center
Dept 001
P.O. Box 843006
Boston, MA 02284-3006
Please disregard electronic and mailed copies if you remit payment in advance.
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or
+1-978-646-2777.
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable
license for your reference. No payment is required.
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ROYAL SOCIETY OF CHEMISTRY LICENSE
TERMS AND CONDITIONS
Jul 30, 2014
This is a License Agreement between Namrata Jain ("You") and Royal Society of Chemistry
("Royal Society of Chemistry") provided by Copyright Clearance Center ("CCC"). The license
consists of your order details, the terms and conditions provided by Royal Society of Chemistry,
and the payment terms and conditions.
All payments must be made in full to CCC. For payment instructions, please see
information listed at the bottom of this form.
License Number 3438931159358
License date Jul 30, 2014
Licensed content publisher Royal Society of Chemistry
Licensed content
publication
RSC Advances
Licensed content title Glycodendrimer coated gold nanoparticles for proteins detection
based on surface energy transfer process
Licensed content author Nicoleta Bogdan,René Roy,Mario Morin
Licensed content date Dec 2, 2011
Volume number 2
Issue number 3
Type of Use Thesis/Dissertation
Requestor type academic/educational
Portion figures/tables/images
Number of
figures/tables/images
1
Format electronic
Distribution quantity 4
Will you be translating? no
Order reference number None
Title of the
thesis/dissertation
Synthesis of carbohydrate-functionalized dendrons for use as
multivalent scaffolds and in self-assembled structures
Expected completion date Aug 2014
Estimated size 100
Total 0.00 USD
Terms and Conditions
This License Agreement is between {Requestor Name} (“You”) and The Royal Society of
Chemistry (“RSC”) provided by the Copyright Clearance Center (“CCC”). The license consists
of your order details, the terms and conditions provided by the Royal Society of Chemistry,
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and the payment terms and conditions.
RSC / TERMS AND CONDITIONS
INTRODUCTION
The publisher for this copyrighted material is The Royal Society of Chemistry. By clicking “accept”
in connection with completing this licensing transaction, you agree that the following terms and
conditions apply to this transaction (along with the Billing and Payment terms and conditions
established by CCC, at the time that you opened your RightsLink account and that are available at
any time at .
LICENSE GRANTED
The RSC hereby grants you a non-exclusive license to use the aforementioned material anywhere in
the world subject to the terms and conditions indicated herein. Reproduction of the material is
confined to the purpose and/or media for which permission is hereby given.
RESERVATION OF RIGHTS 
The RSC reserves all rights not specifically granted in the combination of (i) the license details
provided by your and accepted in the course of this licensing transaction; (ii) these terms and
conditions; and (iii) CCC’s Billing and Payment terms and conditions.
REVOCATION
The RSC reserves the right to revoke this license for any reason, including, but not limited to,
advertising and promotional uses of RSC content, third party usage, and incorrect source figure
attribution.
THIRD-PARTY MATERIAL DISCLAIMER
If part of the material to be used (for example, a figure) has appeared in the RSC publication with
credit to another source, permission must also be sought from that source. If the other source is
another RSC publication these details should be included in your RightsLink request. If the other
source is a third party, permission must be obtained from the third party. The RSC disclaims any
responsibility for the reproduction you make of items owned by a third party.
PAYMENT OF FEE
If the permission fee for the requested material is waived in this instance, please be advised that any
future requests for the reproduction of RSC materials may attract a fee.
ACKNOWLEDGEMENT
The reproduction of the licensed material must be accompanied by the following acknowledgement:
Reproduced (“Adapted” or “in part”) from {Reference Citation} (or Ref XX) with permission of
The Royal Society of Chemistry.
If the licensed material is being reproduced from New Journal of Chemistry (NJC), Photochemical
& Photobiological Sciences (PPS) or Physical Chemistry Chemical Physics (PCCP) you must
include one of the following acknowledgements:
For figures originally published in NJC:
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Reproduced (“Adapted” or “in part”) from {Reference Citation} (or Ref XX) with permission of
The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the
European Photochemistry Association and the RSC.
For figures originally published in PPS:
Reproduced (“Adapted” or “in part”) from {Reference Citation} (or Ref XX) with permission of
The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche
Scientifique (CNRS) and the RSC.
For figures originally published in PCCP:
Reproduced (“Adapted” or “in part”) from {Reference Citation} (or Ref XX) with permission of
the PCCP Owner Societies.
HYPERTEXT LINKS
With any material which is being reproduced in electronic form, you must include a hypertext link to
the original RSC article on the RSC’s website. The recommended form for the hyperlink is
http://dx.doi.org/10.1039/DOI suffix, for example in the link http://dx.doi.org/10.1039/b110420a
the DOI suffix is ‘b110420a’. To find the relevant DOI suffix for the RSC article in question, go to
the Journals section of the website and locate the article in the list of papers for the volume and
issue of your specific journal. You will find the DOI suffix quoted there.
LICENSE CONTINGENT ON PAYMENT
While you may exercise the rights licensed immediately upon issuance of the license at the end of
the licensing process for the transaction, provided that you have disclosed complete and accurate
details of your proposed use, no license is finally effective unless and until full payment is received
from you (by CCC) as provided in CCC's Billing and Payment terms and conditions. If full
payment is not received on a timely basis, then any license preliminarily granted shall be deemed
automatically revoked and shall be void as if never granted. Further, in the event that you breach
any of these terms and conditions or any of CCC's Billing and Payment terms and conditions, the
license is automatically revoked and shall be void as if never granted. Use of materials as described
in a revoked license, as well as any use of the materials beyond the scope of an unrevoked license,
may constitute copyright infringement and the RSC reserves the right to take any and all action to
protect its copyright in the materials.
WARRANTIES
The RSC makes no representations or warranties with respect to the licensed material.
INDEMNITY
You hereby indemnify and agree to hold harmless the RSC and the CCC, and their respective
officers, directors, trustees, employees and agents, from and against any and all claims arising out of
your use of the licensed material other than as specifically authorized pursuant to this licence.
NO TRANSFER OF LICENSE
This license is personal to you or your publisher and may not be sublicensed, assigned, or
transferred by you to any other person without the RSC's written permission.
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NO AMENDMENT EXCEPT IN WRITING 
This license may not be amended except in a writing signed by both parties (or, in the case of
“Other Conditions, v1.2”, by CCC on the RSC's behalf).
OBJECTION TO CONTRARY TERMS 
You hereby acknowledge and agree that these terms and conditions, together with CCC's Billing
and Payment terms and conditions (which are incorporated herein), comprise the entire agreement
between you and the RSC (and CCC) concerning this licensing transaction, to the exclusion of all
other terms and conditions, written or verbal, express or implied (including any terms contained in
any purchase order, acknowledgment, check endorsement or other writing prepared by you). In
the event of any conflict between your obligations established by these terms and conditions and
those established by CCC's Billing and Payment terms and conditions, these terms and conditions
shall control.
JURISDICTION 
This license transaction shall be governed by and construed in accordance with the laws of the
District of Columbia. You hereby agree to submit to the jurisdiction of the courts located in the
District of Columbia for purposes of resolving any disputes that may arise in connection with this
licensing transaction.
LIMITED LICENSE
The following terms and conditions apply to specific license types:
Translation
This permission is granted for non-exclusive world English rights only unless your license was
granted for translation rights. If you licensed translation rights you may only translate this content
into the languages you requested. A professional translator must perform all translations and
reproduce the content word for word preserving the integrity of the article.
Intranet
If the licensed material is being posted on an Intranet, the Intranet is to be password-protected and
made available only to bona fide students or employees only. All content posted to the Intranet
must maintain the copyright information line on the bottom of each image. You must also fully
reference the material and include a hypertext link as specified above.
Copies of Whole Articles
All copies of whole articles must maintain, if available, the copyright information line on the bottom
of each page.
Other Conditions 
v1.2
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable license for your
reference. No payment is required.
If you would like to pay for this license now, please remit this license along with yourpayment made
payable to "COPYRIGHT CLEARANCE CENTER" otherwise you will be invoiced within 48
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hours of the license date. Payment should be in the form of a check or money order referencing
your account number and this invoice number {Invoice Number}.
Once you receive your invoice for this order, you may pay your invoice by credit card.
Please follow instructions provided at that time.
Make Payment To:
Copyright Clearance Center
Dept 001
P.O. Box 843006
Boston, MA 02284-3006
For suggestions or comments regarding this order, contact Rightslink Customer Support:
customercare@copyright.com or +1-877-622-5543 (toll free in the US) or +1-978-646-2777.
You will be invoiced within 48 hours of this transaction date. You may pay your invoice by
credit card upon receipt of the invoice for this transaction. Please follow instructions
provided at that time. 
To pay for this transaction now; please remit a copy of this document along with your
payment. Payment should be in the form of a check or money order referencing your
account number and this invoice number RLNK501365457.
Make payments to "COPYRIGHT CLEARANCE CENTER" and send to: 
Copyright Clearance Center
Dept 001
P.O. Box 843006
Boston, MA 02284-3006
Please disregard electronic and mailed copies if you remit payment in advance.
Questions? customercare@copyright.com or +1-855-239-3415 (toll free in the US) or
+1-978-646-2777.
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable
license for your reference. No payment is required.
